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''Cheshire Puss", Alice began, " Would you tell me, please, which way I ought to go from 
here?" 
"That depends a good deal on where you want to get to," said the Cat. 
"I don't much care where-" said Alice. 
"Then it doesn't matter which way you go," said the Cat. 
"-So long as I get somewhere," Alice added as an explanation. 
"Oh, you're sure to do that," said the cat, "if you only walk long enough." 
From: "Alice Adventures in Wonderland" 
by Lewis CaroU, 1865. 
Voor mijn moeder, 
Voor Laya en de kinderen 
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SCOPE OF THIS THESIS. 
In this thesis several aspects of diagnosis and management of obstructive male infertility are 
discussed. The introduction gives a general overview of both male infertility and 
azoospermia. Diagnostic, genetic and therapeutic aspects of male infertility according to the 
current literature are discussed. The chapter on diagnosis of obstructions of the genital tract 
describes a study on the incidence and management of subtotal obstructions in men with 
severe oligozoospermia. Furthermore, genetic risk factors are investigated in tv.ro studies: in 
men with congenital bilateral absence of the vas deferens the relationship with cystic fibrosis 
is investigated and in men with either azoospermia or severe oligozoospermia cytogenetic 
abnormalities, Y chromosome deletions and cystic fibrosis gene mutations are determined. 
Practical advises for genetic investigations and genetic counselling are given. 
The chapter on management of male reproductive tract obstructions describes the results of 
transurethral resection of cystic lesions in the prostatic gland, causing ejaculatory duct 
obstruction. In a review on microsurgical treatment of the male genital tract, different 
operative techniques, outcome and prognostic factors are discussed extensively, including our 
own results. Finally. the technique of epididymal sperm extraction and intracytoplasmic 
sperm injection are presented together with the results of these combined treatments for men 
with irreparable obstructions of the seminal path. 
The scope of this thesis is to give an overview of recent developments in the diagnosis and 
treatment of obstructive male infertility, and to discuss the genetic risk factors associated with 
these forms of male infertility. 
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Introduction 
Iofertility is defined as lack of conception after at least 12 months of unprotected intercourse (1 ). 
However, in many centres infertility is only considered after 24 months of non-conception. Data 
on the incidence of fertility problems are scarce. The proportion of couples seeking medical 
treatment is estimated at 4%- 17%. The Increasing awareness of infertility and the current avai-
lability of the many techniques of assisted fertilization has changed the patterns of referral. 
Couples tend to ask medical advice after a shorter period of infertility and demand artificial 
reproductive teclmiques at an earlier stage. 
Iofertility affects both men and women. Male causes for infertility are found in 50% of involun-
tarily childless couples. In many couples, however, a male and a female factor coincide. In case 
of a single factor the fertile partner may compensates for the less fertile partner. Iofertility than 
usually becomes manifest if both partners are subfertile, meaning reduced fertility. 
About 10% of the infertile couples are in the group of unexplained infertility. Unexplained 
infertility is a term applied to a couple who have been trying to achieve preguancy and whose 
standard investigations are normal. Finally, 3% of the couples will remain childless, probably 
representing ttue biological infertility (2). 
It has to be emphasised that to categorize :infertility. both partners should be investigated 
simultaneously. In order to evaluate the infertile couple, it is important to get information about 
the duration of infertility, previous pregnancies and the age of the female partner. VVhen the 
duration of infertility exceeds four years of unprotected intercourse, the conception rate per 
month is only 1.5%. At present, many women postpone their pregnancy until they have finished 
their education and have started a professional career. However, the fertility of a woman of35 
years is only 50% of the fertility potential of a woman aged 25 years; by the age of38 years this 
has reduced to only 25%, and over the age of 40 years it is .less than 5%. Female age is the most 
important single variable influencing outcome in assisted reproduction (3). Therefore, in the dia-
gnosis and management of male infertility it is essential to consider the fertility chances of the 
female partner, since this might determine the final outcome. 
In this review several factors influencing male infertility are discussed in detail, with a special 
focus on new insight in the aetiology of idiopathic male infertility, like environmental toxins, 
lifestyle factors and genetic abnormalities. 
Male infertility. 
Reduced male fertility can be the result of congenital and acquired urogenital abnormalities, 
infections of the genital tract, increased scrotal temperature (varicocele), endocrine disturbances, 
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genetic abnormalities and immunological factors (2). No causal factor is found in 40~50% of 
cases (idiopathic male infertility). Many of these men present with no previous history associated 
with fertility problems and have normal findings on physical examination and endocrine 
laboratory testing. Semen analysis reveals a decreased munber of spermatozoa ( oligozoospermi-
a), decreased motility (asthenozoospermia) and many abnormal forms on morphological 
examination (teratozoospermia). Usually these abnonnalities come together and are described as 
the OAT-syndrome (oligo-astheno-teratozoospermia). Table I snmmarizes the main aetiological 
causes of male sub fertility. 
Table I. Aetiology and distribution('/6) of male infertility among 7057 men (2) 
No demonstrable cause 48.5 
Sexual factors 1.7 
Urogenital infection 6.6 
' Congenital anomalies 2.1 
Acquired factors 2.6 
Varicocele 12.3 
Endocriue disturbances 0.6 
hnmunological factors 3.1 
Idiopathic abnormal semen (OAT syndrome) 26.4 
.. Other abnormal1t1es 3.0 
The nnexplained forms of male subfertility may be caused by several factors like chronic stress 
factors, endocrine disruption due to environmental pollution, increased scrotal temperature, reac-
tive oxygen species, and genetic abnormalities. These factors will be discussed in more detail. 
Stress, prolactin and reproduction 
It has been observed that strenuous exercise may lead to impairment of reproductive functions. 
Menarche can be pos1poned by several years. Female marathon rnnners may develop oligo- and 
even amenorrhoea. Also, the pulsatility ofluteinizing hormone (LH) and follicle-stimulariug 
hormone (FSH) is impaired during stress. Although data on exercise in men is less abundant, it 
has also been shown that over-training leads to a decrease of serum testosterone concentration 
and a decrease of sperm concentration that may last several months. Interestingly, an increase of 
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both serum prolactin (PRL) and cortisol has been found during this type of stress; both PRL and 
adrenal corticosteroids are considered as stress factors ( 4 ). 
Hyperprolactinaemia in men and women due to prolactin-secreting pituitary adenomas is 
associated with loss oflibido, potency and menstrual cycle disturbances, respectively. However, 
the development of these clinical manifestations, apparently due to hypogonadotrophic-
hypogonadism during hyperprolactinaemia, might also be explained by the size of the tumour 
and destruction of normal pituitary tissue, rather than by PRL itself. 
In rats, hyperprolactinaernia leads to suppression of gonadotrophin-releasing hormone (GnRH)-
release from the hypothalamus, suppression of serum gonadotrophins and gonadal steroids (5). It 
has been shovm both in vivo and in vitro that PRL is able to activate the hypothalamus-pituitary-
adrenal (HP A) axis, primarily by stimulation of corticotrophin-releasing factor (CRF). 
Subsequently, CRF is able to stimulate production of pro-opiomelanocortin (POMC) and fi-
endorphin. which have been shown to be potent suppressors of GnRH-release. This mechanism 
has also been shown during stress (6). 
In conclusion, the suppressing effects ofPRL and stress on gonadal function in rats are at least 
partly due to the activation of the HP A-axis. Evidence for this mechanism in men is still 
fragmentary. 
Endocrine disruption 
In 1992 Carlsen eta/. published a meta-analysis of semen quality over the period 1938-1990 and 
found a significant decrease of sperm-concentration and semen-volume, together with an 
increase of cryptorchidism, hypospadias and testicular cancer (7). This study prompted several 
investigators to evaluate their data on semen-quality. The studies of Auger et a/.(8) and Irvine et 
a!. (9) provided evidence for a decline in sperm concentration and total number of motile sperm. 
Other studies argue that there has not been a decrease in semen quality over the past 20-50 years 
(1 0,11). However, the reported decrease in sperm-concentration may seem difficult to reconcile 
with the absence of any detectable decrease in male fertility. 
Another remarkable observation is the increased incidence of testicular cancer (12). The 
epidemiological data indicative of an increasing incidence of cryptorchidism (13) are unequivo-
cal. Birth data from several reports have indicated a substantial increase in prevalence of 
hypospadias (14). The contradictory observations on sperm-quality and the unequivocal data on 
testicular cancer, cryptorchidism and hypospadias lead to the conclusion that the available data 
are sufficient to raise concerns, especially since it has been questioned whether environmental 
toxins, often estrogenic in effect, may affect male reproductive health. 
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PRL 
tACTH 
+ testosterone 
Figure I. Central effects of prolactin on the hypothalamic-pituitary-gonadal axis. (PRL, 
prolactin. CRF, corticotrophin-releasing factor. POMC, pro-opiornelanocortin. GnRH, 
gonadotrophin-releasing hormone. ACTH, adrenocorticotrophic hormone. LH, luteinizing 
hormone. ARC, arcuate nucleus. MPOA, medial preoptic area. PVN, paraventricular nucleus) 
Short arrows indicate changes in levels. 
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It has been hypothesised that these male reproductive disorders might be explained by over· 
exposure to estrogens or estrogenic chemicals in foetal life (15). However, high doses of diethyl-
stilbestrol (DES) did not lead to impairment offertility in men who had been exposed to DES in 
utero (16), although congenital malformations of the genitalia were reported three times as often 
by the DES-exposed men as by the sons of the women in the placebo group. Another observation 
that challenges this hypothesis is the persistent difference in the incidence rate of testicular 
cancer in the Scandinavian countries in men exposed in utero in the mid-l960s to p,pl-DDE, the 
main DDT -metabolite, an organochlorine pesticide with known estrogenic and androgenic 
effects (17). 
The major routes of exposure to environmental chemicals are thought to be dietary, 
environmental from pollution of air and water, domestic and occupational. Nevertheless, any 
proof that exposure to estrogenic compounds may lead to deterioration of reproductive function 
only comes from wild life. 
Scrotal temperature. 
In humans both testes are positioned outside the abdomen to induce a temperature that is 2-3° C 
below the body temperature. Spermatogenesis and epididymal function are optimal at this 
temperature. Scrotal cooling is at its best in a standing position and during walking. Increased 
scrotal temperature impairs sperm production and epididymal function, resulting in low sperm 
numbers and poor motility (18). The function of the epididymis is storage and maturation of 
spermatozoa and passage through the organ is essential for normal fertilization. It has been 
shown in animals that the speed of transportation through the epididymis is increased in case of 
high scrotal temperature. Conditions like a non-scrotal position of the testes (retractile testis, 
cryptorchidism), varicocele and fever influence spermatogenesis by increasing the gonadal 
temperature. Also, hot baths, frequent sauna visits, isolating underwear and occupational 
exposure to strong heat sources can induces alterations in spermatogenesis and increase the inci-
dence of male subfertility. Measuring scrotal temperature in men with varicocele before and after 
ligation of the spermatic vein supported the view that varicocele-related damage to the testis 
results from a lack of adequate cooling (19). 
After many years of study, some insight is finally being gained into the mechanism( s ), which 
may cause the destruction at body temperature. In mice, germ cells show a stress response at an 
appreciably lower temperature than somatic cells. Heat shock factor 1, involved in the regulation 
of heat shock proteins, is activated in spermatocytes at a threshold temperature of35° C instead 
of 42° C. as in somatic cells. 
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Increased scrotal temperature is usually a preventable cause of male infertility: varicocele 
treatment and simple avoidance of exogenous heat exposure can improve semen quality substan-
tially. 
Reactive O::\)'gen species. 
In cells reactive oxygen species (ROS) are generated during oxidation of organic substances. 
Most cells have the ability to protect themselves against damage by the enzymes superoxide 
dismutase, catalase and glutathione peroxidase and by antioxidants like taurine, ascorbic acid and 
tocopherol. The deleterious effect ofROS on semen quality has been documented by numerous 
investigators and was recently reviewed (20). 
There are several reasons why spermatozoa are more vulnerable to ROS than other cells. 
First, the sperm membrane contains a higb level of polyunsaturated fatty acids (PUFAs), 
which are extremely susceptible to peroxidation. Peroxidative damage may result in a loss of 
membrane functions and may lead to a reduction of fertilizing ability, motility and viability. 
Second, in contrast to other cells, spermatozoa have a very limited system to repair damaged 
structures as a consequence of their small amount of cytoplasm and an inactive, highly 
condensed chromatin. Third, spermatozoa are equipped with a poor defense system against 
ROS; while catalase is fully absent, glutathione peroxidase and superoxide dismutase are 
present in relatively low amounts. 
The possible sources ofROS in semen are spermatozoa and leucocytes. Under physiological 
conditions ROS are mediators of normal sperm function, like capacitation, hyperactivation and 
the acrosome reaction. High levels ofROS can produce extensive protein damage, cytoskeletal 
modifications and functional impairment, like reduced motility and sperm-oocyte fusion (21). 
At the moment it is not clear where in the male or female reproductive tract most damage to 
sperm is induced by ROS. Our knowledge about ROS-induced damage is mainly based upon stu-
dies carried out with ejaculated specimen. These investigations have demonstrated that ROS is 
generated by leucocytes and by spermatozoa themselves and that in general spermatozoa from 
oligozoospermic samples generate more ROS than those from nonnospermic samples. 
In spinal cord injured (SCI) patients ROS levels are even higber than in oligozoospermic men 
and seem to be associated with urogenital infection and the presence of polymorphonuclear 
neutrophils. Sperm motility is usually very low in ejaculated sperm from SCI patients. 
Reduction of oxidative stress can be accomplished by antibiotic treatment, but in patients with 
asymptomatic leucocytospermia this has usually little effect on the sperm quality. Other options 
for treatment can be antioxidant supplementation like alpha-tocopherol (Vitamin E) and ascorbic 
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acid (Vitamin C). Separation of the good spermatozoa from inferior ones and from leucocytes by 
centrifugation over density gradients and swim~up procedures may help to prevent ROS-induced 
damage in the ejaculate. 
Genetic abnormalities. 
Although chromosomally derived infertility has long been recognized, the development of 
intracytoplasmic sperm injection (ICSI) as a method to overcome severe spermatogenic defects 
has prompted many investigators to further explore the genetic basis of male infertility. In a 
recent study we confirmed that male infertility is associated "With several genetic abnormalities 
such as constitutive chromosome abnormalities, submicroscopic deletions of theY chromosome 
and mutations in the cystic fibrosis gene (22). 
The chance of having a chromosomal defect increases with the severity of the spermatogenic 
defect (23). In a recent study the frequency of karyotypic abnormalities in 1007 males with 
infertility was found to be as high as 6.5%, of which 63% were sex chromosome aneuploidies 
(24). From fluorescence in situ hybridization (FISH) labelling of sperm chromosomes it was 
concluded that infertile men carry a high number of abnormal spermatozoa. In case of OAT 
almost 20% of the spermatozoa were found to be aneuploid. Many of these spermatozoa are the 
result of meiotic pairing disruption. It has been suggested that these pairing abnormalities in 
infertile men could lead to meiotic arrest in some cells causing oligozoospermia and aneuploidy 
in other cells capable of completing spermatogenesis (25). 
DNA-analysis of theY chromosome revealed deletions in a region of the long arm, also known 
as the iAzoospermia Factor" (AZF) region, in 5-15% of infertile men vvith oligozoospermia and 
azoospermia (26). These de novo deletions are predominantly fmmd in men with severe oligos-
permia and non..abstructive azoospermia, vvith normal physical findings and normal levels of 
gonadotrophins. Histological studies of testicular biopsies from men carrying aAZF deletion 
exhibit- dependent upon the site of the deletion- a \Vide spectrum of spermatogenic defects from 
complete absence of germ cells (Sertoli-cell-only syndrome) to maturation arrest with occasional 
production of mature, condensed spermatids. 
Men vvith defects of the genital ductal system, like congenital bilateral absence of the vas 
deferens (CBA VD), were found to carry different mutations of the cystic fibrosis transmembrane 
conductance regulator ( CFTR) gene (27). CBA VD has recently been described as a genital form 
of cystic fibrosis (CF). Cystic fibrosis has a wide range of clinical manifestations with pancreatic 
and pulmonary insufficiency on the severe end of the phenotypic spectrum and infertility due to 
congenital anomalies of the genital tract on the other end. 
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It is estimated that 20% of idiopathic male infertility can be explained by genetic abnormalities. 
The use of!CSI in these men may lead to offspring with an increased risk of an unbalanced 
chromosome complement, male infertility due toY-linked tnrnsmission of an AZF deletion and a 
form of cystic fibrosis in case ofCF-related genital abnormalities. Unbalanced chromosome 
complement vvilllead to either an increased risk for miscarriage or~ in case of ongoing pregnan-
cy, to multiple congenital abnormalities and mental retardation. Sex-chromosomal aneuploidy 
and Y -linked transmission of an AZF deletion will lead to a new generation of infertile men, 
whose ability to reproduce will be completely dependent on assisted reproductive techniques. 
The development of microsurgical epididymal sperm aspiration (MESA) and ICSI has greatly 
improved the chances for CBA VD males to father their own children. However, in these couples 
there will be an increased risk ofhaving children with CF or CBA VD, particularly when the 
female also carries a CFTR gene mutation. We conclude that all men with idiopathic 
oligozoospennia or azoospermia should be offered genetic testing and counselling before 
assisted reproduction is considered. 
Conclusions. 
Unexplained male infertility can be the results of environmental toxins causing endocrine 
disruption, lifestyle factors like stress, immunological factors and genetic abnormalities. 
The need for further research on the subject of pathophysiology of idiopathic male infertility has 
increased due to the recent advancements of artificial reproductive techniques such as ICSI. 
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Introduction 
There has recently been renewed interest in azoospennia, mainly because of new therapeutic 
options for obstructive azoospennia and some cases of non-obstructive azoospermia. 
Intracytoplasmic sperm injection (ICSI), a new In Vitro Fertilization (NF) technique, has proved 
to be successful in cases of severe oligospermia, were conventional IVF failed to achieve 
fertilization (1 ). Injection of a single sperm directly into the oolemma of the oocyte gives a 60-80 
%chance offertili7..ation and a 25% chance of an ongoing pregnancy (Figure 1). More recently 
this technique has also been applied successfully with epididymal and testicular sperm. 
Microsurgical epididymal sperm aspiration (MESA,2) and testicular sperm extraction (TESE,3) 
are new techniques by which viable spermatozoa can be aspirated for NF-ICSI procedures 
These techniques offer a chance of biological parenthood to couples for whom pregnancy used to 
be impossible. These techniques also raise questions about the safety of using immature sper-
matozoa for micromanipulation. Several congenital diseases and genetical disorders, leading to 
ductal obstruction or testicular failure can be transferred to a subsequent generation by these 
artificial reproduction techniques (ART). Our knowledge of the genetics and pathophysiology of 
azoospermia is still limited and more research on this issue is urgently requested. Currently the 
technical advances are ahead of the basic understanding of the mechanisms that lead to ductal 
obstruction or testicular failure. Our knowledge of the genetics and pathophysiology of 
azoospermia is limited and more research on this issue is urgently required. 
Classification. 
Approximately 85 percent of the couples achieve their desired pregnancy within one year of 
unprotected intercourse. In the remaining couples another 30~50 %pregnancies occur in the 
following year. Ultimately, 4% of the couples remain childless. Azoospermia and anovulation 
are common causes in these cases. 
Male factors account for at least 50% of all cases of infertility: azoospermia is found in 20%. A 
classification of azoospermia can be based on obstructive and non-obstructive azoospermia. 
Non-obstructive azoospermia can be subdivided in several etiological categories. Table 1 
sununirizes the most conunon causes of testicular failure. For the definitive diagnosis of 
testicular failure a testicular biopsy is needed. This procedure is usually performed only in cases 
where physical examination and follicle-stimulating hormone (FSH) are normal, when ductal 
obstruction is suspected and testicular failure has to be ruled out. Since FSH feedback is 
determined by the function of the sertoli cells, maturation arrest and even some form of germinal 
aplasia (Sertoli cell only syndrome) can be present with normal FSH levels (4). Testicular failure 
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is found in a third of the cases of azoospermia with normal testicular size and normal FSH. 
Simply counting the nwnber of mature spermatids gives the most reliable quantification of the 
testicular function. 
Common causes of testicular insufficiency are cryptorchidism, testicular torsion, viral (mumps) 
orchitis, drug-induced testicular failure (cytotoxic therapy), irradiation, endocrinopathy and 
genetic causes, such as the Klinefelter's syndrome. In at least half of all cases no identifiable 
cause of testicular failure is found (idiopathic forms). 
Since mild forms of maturation arrest can be caused by obstruction and only a few mature 
spermatozoa are needed for fertilisation with ICSI-MESA and ICSI-TESE procedures, an 
accurate diagnose is mandatory in cases of azoospermia with normal FSH levels ( 5). It should be 
remembered that maturation arrest and even germinal aplasia can be found next to normal 
spennatogenesis in the same testis. 
Table 1. A classification of non-obstructive azoospermia on the 
basis of the results of testicular biopsy 
1 Maturation arrest. 
! - Idiopathic 
! - Cryptorchidism 
- Viral orchitis (mumps) 
- Drugs, cytotoxic therapy 
- Irradiation 
- Systemic illness 
- Environmental toxins 
2 Gemllnal aplasia (Sertoli cell only syndrome) 
! -Idiopathic 
' 
-Drugs 
- Irradiation 
-Klinefelter's syndrome '-'lith mosaicism 
3 Seminiferous tubular sclerosis 
-Klinefelter's syndrome 
- Other genetic abnormalities 
-Vascular injury, testicular torsion 
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Figure 1. Intracytoplasmic sperm injection. A single sperm is injected directly into the oolemma 
(cytoplasm) of a 2PN oocyte. 
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Table 2. A classification of obstructive azoospermia on basis of ductal 
obstruction due to congenital and acquired causes 
1 Epididymal obstruction 
Congenital forms 
Acquired fonns 
2 Vas deferens obstruction 
Congenital forms 
Acquired forms 
3 Ejaculatory duct obstruction 
Congenital forms 
Acquired forms 
~Capital blocks/ Young's syndrome 
~ Post~infcctivc (epididymitis) 
~Post-surgical (epididymal cysts) 
-Congenital absence of the vas deferens 
- Post~vasectomy 
- Post~surgical (hernia., scrotal surgery) 
-Prostatic cysts (Mullerian cysts) 
- Post-surgical (bladder neck surgery) 
~ Post-infective 
Obstructive azoospermia can be divided in congenital forms and acquired forms of ductal 
obstruction (Table 2). Obstruction is found in 9% of males with infertility and is frequently 
caused by epididymal blockage (4.4%), secondary to epididymal infection (6). Congenital 
blockage of the ductal system occurs less frequently: absence of the vas deferens is found in 2% 
of infertile males and can be genetically associated with cystic fibrosis (7). Caput epididymal 
blocks, as in the Young's syndrome, are rare (8). 
Aetiological factors. 
In at least 50% of the cases the cause of the testicular failure is not identified. Although 
varicoceles are present in 20-30% of the males with fertility problems, a causal relation with 
azoospermia is unproven. Varicoceles are usually associated with oligospermia and some form 
of maturation arrest is found on testicular biopsy. 
Cryptorchidism accounts for 4.4% of the cases of azoospermia (9). Progressive testicular failure 
is found in untreated cryptorchidism due to the increased temperature of the extrascrotal position. 
Furthermore, epididymal abnormalities are present in 40% of patients (10). On testicular biopsy 
defective spermatogenesis can be found, frequently also in the contralateral testis. It is suggested 
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that a congenital dystrophy causes the maldescent as well as the impaired spermatogenesis and 
the increased chance of developing a testicular tumour. 
Testicular torsion usually occurs unilaterally. It may affect fertility by an immunological 
response on both testes. This mil lead to subfertility, though azoospermia is rare in these cases. 
Viral orchitis is found to be an cause of testicular failure in less than 5% of infertile cases. 
Mumps orchitis is rare in pre-pubertal boys, but is a common complication after puberty, 
occuring in 3 7% of cases. The mumps virus dirtectly affects the testis, causing an inflammatory 
reaction with cell death and tissue necrosis due to raised intratesticular pressure. Testicular 
biopsy shows mononuclear infiltration and atrophy of the seminiferous tubules. Severe bilateral 
orchitis may lead to hypergonadotropic hypogonadism. 
Several drugs and industrial agents are associated with testicular failure. Cytotoxic therapy for 
cancer and autoimmune diseases has been reported to cause azoospermia in up to 68% (11 ). The 
use of chemotherapy has increased over the last decade, since leuk:aemias, Hodgkin's disease, 
testicular cancers and other malignancies can be treated successfully. This mil lead to an 
increase of the number of infertile men in the future. The effect on spermatogenesis depends on 
the duration and severity of the specific agents used. Alkylating drugs and combination 
chemotherapy regimens in high doses -will cause permanent testicular failure in more than half of 
the patients. It should be noted that pre-treatment semen analysis is abnormal in 60% of cases of 
testicular cancer. Furthermore, retroperitoneal lymph node dissection in testicular cancer may 
affect seminal emission, causing an ejaculation or retrograde ejaculation due to hypogastric nerve 
damage. 
Several drugs may influence spermatogenesis: cyclosporin, sulphasalazine, anabolic steroids, 
nitrofurantoin, cimetidine, spironolactone, colchicine and allopurinol are Jmovvn for their 
gonadotoxic effects. Usually, the effects are reversible after dicontinuing medication. The drugs 
may interfere mth the hypothalamic-pituitary-gonadal axis (anabolic steroids, cimetididne, 
cyclosporin), impaire testosterone biosynthesis (spironolactone, sulphasalazine) or have a direct 
gonadotoxic effect (nitrofurantoin). Sulphasalazine, frequently used as treatment for 
inflanunatory bowel disease, causes abnormal semen parameters in 86% of patients ( 1 0). 
Exposure to chemical agents and environmental toxins may cause permanent damage to the 
testis. Dibromochloropropane (DBCP), a mdely used pesticide, has been reported to cause 
azoospermia in 25% of banana workers (12). Several industrial metals, especially lead are 
associated mth decreased fertility (13). More recently, evidence for decreasing quality of 
semen, due to environmental factors has been associated -with fetal exposure to exogenous 
oestrogens (14 ). Also, a two-fold increase in genito-urinary malformation (hypospadias, 
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cryptorchidism, testicular cancer) is reported, possibly related to exposure to oestrogens and 
oestrogenic chemicals like dioxin. In a meta-analysis of the literature of the past 50 years, 
Carlsen eta/. (15) found a reduction of semen volume and sperm concentration of 50%. In 
animal studies, a dose-dependent reduction of testicular size and number of Sertoli cells have 
been observed after exposure to oestrogenic chemicals ( 16). 
Irradiation of the lower abdomen may be responsible for azoospermia. Fast proliferating germ 
cells are highly radiosensitive. Azoospermia usually results from dosages greater than 50 rad. 
Recovery may take several years. Pregnancies follov.ring radiotherapy or chemotherapy have not 
shown increased incidence of congenital anomalies in the offspring ( 17). 
Chronic diseases like renal insufficiency and liver cirrhosis are associated vvith testicular failure. 
The mechanism is unknown, but hormonal impairment is likely. Several congenital diseases can 
cause infertility. cystic fibrosis is associated with azoospermia, due to bilateral absence of the vas 
deferens. Myotonic dystrophy causes tubular atrophy, not affecting Ieydig cell function. Von 
Rippel-Lindau disease is associated with cystic degeneration ofthe epididymis. Young's 
syndrome is characterised by chronic sinopulmonary infections and obstructed azoospermia by 
epididymal blockage. The immotile cilia or Kartagener' s syndrome is associated with a history 
of respiratory infections, situs in versus and defective spermatogenesis. 
Although much attention is given in the literature to endocrine disorders, they account for less 
than 5% of cases of male infertility ( 18). Pituitary disease is the most common cause and should 
be suspected in cases of hypogonadism, which is often first diagnosed after puberty. Gonadotro-
pic deficiency associated with normal pituitary function is found in the Kalmann' s syndrome, an 
infrequent but treatable cause ofhypogonadotropic hypogonadism. The syndrome is sometimes 
associated with multiple congenital anomalies, such as tuidline defects (cleft palate), deafness, 
cryptorchidism and renal pathology. Puberty is delayed because of gonadotrophin-releasing 
hormone (GnRH) deficiency. Other congenital endocrine abnormalities are extremely rare 
(Prader-Labhart-Willy syndrome, Laurence-Moon-Biedl syndrome, Pasqualini syndrome). 
Acqnired endocrine disorders mainly concern hyperprolactinaernia, due to pituitary tumors. 
Adrenal and thyroid abnormalities may occasionally cause testicular failure with maturation 
arrest. 
Obstructive azoospermia can be classified into congenital and acquired fonns of ductal 
obstruction. Congenital forms mainly concern bilateral absence of the vas deferens, capital bloc-
kage of the epididymis (Young's syndrome) and Mullerian duct cysts in the central zone of the 
prostate. Surprisingly, congenital ductal obstruction is often associated vvith pulmonary illness, 
such as cystic fibrosis (absence of the vas deferens) and chronic sinopulmonary infections 
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(Young's syndrome, immotile cilia syndrome). Obstruction in these cases occurs from epidi-
dymal blockages by inspissated secretions, due to defective electrolytes conductance (6,8). 
Spermatogenesis is usually normal. Congenital absence of the vas deferens can occur unilateral, 
bilateral and can be partial or complete; the anomaly is found in approximately one of thousand 
males. Congenital bilateral absence of the vas deferens (CBA VD) is strongly associated with 
cystic fibrosis. Y otmg' s syndrome, a combination of obstructive azoospermia and chronic 
sinopulmonary infections, occurs in 3% of the infertile males. Men with this syndrome have 
mildly impaired respiratory function. Spermatogenesis appears normal, but sperms derived from 
the caput epididymis have been shovm to have a low fertilising capacity, because of their short 
passage tbrough the epididymis. 
Distal ductal obstruction, caused by M)lerian duct cysts are characterized by painful ejacnlation 
with low volume of ejaculate. Oligospermia or azoospermia is usually present. The diagnosis is 
made by transrectal ultrasound of the prostate and the vesicula sern.inalis: a midline cyst is seen 
in the central zone of the prostate, together with a dilatation of the ejaculatory ducts and vesicula 
seminalis (19,20). The congenital forms of ejaculatory duct obstruction are sometimes associated 
with abnormalities and obstructions in the more proximal parts of the ductal system. 
Acquired ductal obstructions account for most of the cases of obstructive azoospermia. 
Infections of the ductal system and surgery of the scrotum and the groin are the most important 
causes of this type of obstructions. Ductal Infections used to be caused by ascending urinary tract 
infections, gonorrhoea and tuberculosis. Recently, Chlamydia trachomatis has been recognised 
as an infective agent, causing multiple blocks of the ductal system. The blocks are asymmetrical 
and most often seen in the corpus and the tail of the epididymis. A history of epididymitis or 
urethritis is found in many cases. Coexisting vasal blocks are common (Figure 2). 
Post-surgical causes of ductal obstruction are nowadays mainly the result of previous vasectomy 
procedures. Vasectomy reversal is currently performed in 1-2% of the cases and has been shown 
to be successful in terms of pregnancies in 50-70% of patients. Surgical damage near the vas 
deferens may cause innenration problems, leading to a functional obstruction. This is most likely 
to occur in the most proximal part of the vas deferens. Ductal obstructions can also occur from 
epididymal cysts extirpation, iatrogenic vasal ligation (hernia repair, orchidopexy) and previous 
bladder neck surgery. 
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Figure 2. Epididymal obstrnction by a caudal epididymal blockage. Vasography should be 
peifonned to rule out associated vassal blockage. 
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Genetic aspects of azoospermia. 
It has been recognised for many years that chromosomal abnormalities occur more often in 
males with azoospermia. Also, several congenital abnormalities can be associated with testicular 
dysfunction. As mentioned before, pulmonary dysfunction is observed in cases of congenital 
ductal obstruction. 
Chromosomal abnormalities are estimated to be present in 15% of the azoospermic patients 
(21,22,23). Numerical chromosomal abnormalities are most often associated with Klinefelter's 
syndrome (47,XXY), resulting from a meiotic non-disjunction of the gametes. The syndrome 
occurs in 0.2% of the males, but is more prominent in cases of azoospermia (2.7%). A state of 
hypergonadotropic hypogonadism is found and azoospermia is usually present, although cases of 
mosaicism (46)(Y/47xxY) may appear to be subfertile. The syndrome is sometimes associated 
with mental retardation or various psychiatric disorders. FSH levels are high and on testicular 
biopsy tubular sclerosis is found. Testosterone levels are low in 40% of the cases and 
testosterone should be substituted. 
Structural chromosomal abnormalities mainly concern translocations and deletions of theY 
chromosome and are found in approximately 10% of the azoospennic males (22). Deletions of 
the long-arm of the Y chromosome are held responsible for some cases of unexplained 
azoospennia. Microdeletions can only be found by fluorescence in situ hybridisation (FISH) 
techniques, using Y chromosome specific DNA fragments as probes for detection (21). 
Several congenital syndrome's present with testicular failure: the Prader-Willi syndrome is 
associated with abnormalities of chromosome 15 and demonstrate a state of hypogonadism due 
to a lack of GnRH. Down syndrome is associated with maturation arrest to germinal aplasia. 
Testicular dysfunction is seen in 80% of the cases of myotonic dystrophy. In Von Rippel-Lindau 
disease cystic degeneration of the epididymis can be found to cause obstruction. 
Congenital bilateral absence of the vas deferens (CBA VD) is found in 1-2% of infertile males 
and is found in almost all male cystic fibrosis patients. A genetic relationship with cystic fibrosis 
(CF) has recently been suggested (25.26). The CF gene, the cystic fibrosis transmembrane 
regulator ( CFTR) gene, is localised on the long arm of chromosome 7 and encodes for a large 
protein ( CFTR, 250,000 base pairs), which is situated in the cell membrane of epithelial tissue. 
CFTR is responsible for the electrolyte transport through the cehnembrane and protein 
dysfunction may cause deficient chloride excretion. This will result in a thick mucus with 
obstruction of epithelial glands of the pancreas (pancreatic insufficiency with malabsorption) and 
recurrent pulmonary infections due to highly viscous mucus. Since the discovery of the CFTR 
gene mild forms ofCF have been found with a deficien~ but not absent chloride excretion and 
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are associated with a better life expectance than the severe cases ofCF (26). The disease is 
inherited in an autosomal recessive manner; tvvo CFTR gene mutations are required for the deve-
lopment of a CF phenotype. One gene is inherited from the mother, one from the father. The 
carrier risk for CF shows significant racial variance. In most western countries the carrier risk for 
(one) CFTR gene mutation is 1:25. CFTR gene mutations are found in 87% ofCF patients and 
in 78% ofCBA VD patients. The delta F508 mutation is most prominent in CF, but already more 
than 500 different mutations have been found, most of them appearing as a point mutation, found 
in a single patient. The risk of inheritance ofCF or CBA VD is mainly determined by the 
partner's genetic investigation: if she carries a CFTR gene mutation (1:25) there is a 50 percent 
chance of a form ofCF (severe, mild, CBA VD) in the offspring. 
Treatment of azoospermia. 
Obstructive azoospermia, caused by epididymal and vasal blocks and prostatic cysts can be 
successfully treated by (micro )surgery. Vasectomy reversal is a conunon microsurgical 
procedure and gives patency in 80-90% and pregnancies in more than half of the cases (27,28). 
The interval between the vasectomy and the vaso-vasostomy is of major prognostic significance: 
after an interval of more than 10 years pregnancies occur in less than 20%. Fibrosis of the 
epididymis, due to a prolonged obstruction, is the main reason for failed vasectomy reversal. 
Antisperrn antibodies occur in most cases after vasectomy and may play an important role in 
persistent infertility, despite successful reversal. We have performed over 260 microsurgical 
vasectomy reversal procedures: patency was obtained in 86% and pregnancies in 51%. Second 
reversal after failed first procedure showed pregnancy in only 27% of the cases (unpublished 
results). 
Epididymal blocks can be treated by vaso-epididymostomy in cases of normal testicular function 
and patent vas deferens. Testicular biopsy and vasography should be performed prior to surgery. 
In one-third of the scrotal explorations an empty epididymis is found, despite normal testicular 
biopsy. Multiple blocks, caused by a Chlamydia trachomatis infection are difficult to treat. 
Patency is reached in 36-78% of cases and pregnancies are reported in 21~56% after vaso~ 
tubulostomy (29). Pregnancies after microsurgery for capital blocks occur in less than 30%, 
because of poor fertilisation capacity of the spermatozoa after only short passage tlrrough the 
epididymis ( 6). 
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Figure 4. Transrectal ultrasound images. showing a midline prostatic cyst in the central zone of 
the prostate (ejaculatory duct cyst) and dilated seminal vesicles. 
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Distal ductal obstructions are caused by prostatic cysts or post-inflanunatory obstruction of the 
ejaculatory ducts. A low-volume ejaculate is usually found. The diagnose is made by transrectal 
ultrasound, showing dilatation of the vesicula seminalis and ejaculatory ducts. Trans-urethral 
loop resection with unroofing of the cyst and opening of the ejaculatory ducts can be successful 
in restoring fertility in selective cases (19,20). 
The congenital absence of the vas deferens cannot be treated by microsurgery. Pregnancy can 
only be reached by aspiration of viable sperms from the epididymis (MESA) for IVF-ICSI 
procedures. The results of:MESA-NF procedures, however, are disappointing. Ongoing 
pregnancies are reported in less than I 0 percent. Decreased sperm motility and fertilisation 
capacity is the main reason for these poor results (5). Intracytoplasmic sperm injection, however, 
has been shown to give high number of fertilisation rates with ejaculated, epididymal, frozen-
thawed and testicular sperms (1,3,5). Ongoing pregnancy is observed in 20-30% per cycle. The 
implantation rate after ICSI is 40-50%, but pregnancy loss occurs in at least 26%. 
Non-obstruction is found in SO% of cases of azoospermia and used to be a non~ treatable 
condition. Limited results are available from ICSI procedures with testicular biopsy sperms. 
They appear to fertilize normal in 84% and (early) pregnancies are obtained in almost 40% (3). 
In the near future some cases of non-obstructive azoospermia will appear to be treatable by 
TESE-ICSI procedures. 
In the series of the Free University of Brussels, 130 children born after ICSI were compared 
to the follow-up of children born after IVF. No significant differences in minor and major 
malformations were found. Most ofthe children were born after ICSI procedures with 
ejaculated sperms) the data of the offspring from azoospermic patients are not yet available. 
Numerical chromosomal abnormalities were found in 1.3% (0.5% in fertile couples) and 
major malformations were found in 3.5% (23). A longer follow-up of the children is, 
however, required to establish the true incidence of complications, since several abnormalities 
may appear later in life (CF, inborn errors of metabolism, pulmonary dysfunction, infertility). 
Genetic screening is advised by pre-implantation diagnosis or pre-natal screening. A close 
cooperation vvith a genetic institute is therefore mandatory for safe ICSI procedures. 
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ABSTRACT. 
Bilateral obstruction of the male reproductive tract is suspected in men with azoospermia, normal 
testicular volume and normal FSH. A testicular biopsy is required to differentiate between 
obstruction and a testicular insufficiency. Unilateral or subtotal bilateral obstructions and 
epididymal dysfunction may cause severe oligozoospermia in men with a normal intra-testicular 
spermatogenesis. However, information on spermatogenesis in oligozoospermic men is lacking, 
since testicular biopsy is not routinely performed. 
Men with a sperm concentration of< 1 x 106 spermatozoa/ml were investigated for possible 
partial obstruction, by performing a testicular biopsy under local anaesthesia. Spermatogenesis 
was determined by the Johnsen scoring method. A testicular biopsy was performed in 78 men 
with severe oligozoospermia. The medical history showed male accessory gland infection in 
12.8%, previous hernia repair in 14.1 %, and a history of cryptorchidism in 12.8%. A normal or 
slightly disturbed spermatogenesis (Johnsen score >8) was present in 39/78 (50%) men. Hernia 
repair occurred more often in men with a normal spermatogenesis. A varicocele was 
predominantly seen in men v.rith a disturbed spermatogenesis. FSH was significantly lower 
(p<O.OOOl) in men with normal spermatogenesis. Microsurgical repair of the seminal tract was 
performed in 9 men and resulted in significantly improved semen quality in 4 and spontaneous 
pregnancy in 2 couples. Alternatively, intracytoplasmic sperm injection (ICSI) was performed in 
24 couples and resulted in 4 (16.6%) ongoing pregnancies. 
Subtotal obstruction of the male reproductive tract is a frequent cause of severe oligozoospermia 
in men with a normal testicular volume and a normal FSH. In other cases an epididymal 
dysfunction might explain the oligozoospermia in men with a normal testicular biopsy score. 
Microsurgical repair and epidid)'Tilal sperm aspiration for cryopreservation should be considered 
in men with severe oligozoospermia and normal spermatogenesis. 
KEY WORDS: SUBTOTAL OBSTRUCTION- MALE GENITAL TRACT- MALE 
INFERTILITY- OLIGOZOOSPERl'\IIA, 
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INTRODUCTION 
Partial obstruction of the male reproductive tract is defined as the presence of oligozoospermia 
with normal or nearly normal spermatogenesis (1 ). This diagnosis can be suspected in men with 
severe oligozoospermia, nonnal physical findings and normal serum follicle~stimulating 
hormone (FSH). Indicative for a subtotal obstruction is a history of inguinal or scrotal surgery 
and recurrent genital infections. Other features that suggest obstruction are low seminal volume, 
epididymal congestion, enlarged seminal vesicles and cystic lesions of the epididymis and 
prostate. 
For the definite diagnosis of obstruction a testicular biopsy is required, confirming the presence 
of mature spermatids and spermatozoa in the seminiferous tubules (2,3). Because of the invasive 
nature of this procedure, the limited results of surgical treatruent of obstructions of the seminal 
path and alternative options like assisted reproductive traetments, testicular biopsies are not 
routinely performed in men v.rith oligozoospermia. 
However, in selective cases the state of spermatogenesis could be assessed, both for estimation 
of genetic risks factors specifically related to obstructive male infertility ( 4) and to determine the 
possibility of performing a microsurgical vasoepididymostomy together with an epididymal 
sperm aspiration and cryopreservation. 
In men with progressive deterioration of the semen quality and in men with a low semen volume 
an obstruction of the ejaculatory ducts can be found on transrectal ultrasound of the prostate (5). 
Both surgical incision of cystic lesions in the prostate and aspiration of spermatozoa from the 
seminal vesicles are treatment options that may require information on the state of the 
spermatogenesis in advance, since obstructions of the epididymis frequently coincide with 
obstructions of the ejaculatory ducts (6). 
To determine the true incidence of subtotal obstruction of the male reproductive tract in 
oligozoospermia and to offer the option of surgical exploration and microsurgical reconstruction 
we have performed a testicular biopsy in 78 patients with< 1 million spermatozoalml and 
analysed the results of the testicular histology, in relation to the medical history, the physical 
findings and the FSH. Also, the results of microsurgical repair of the seminal tract in men with 
normal spermatogenesis and the results ofiCSI were determined in these patients. 
PATIENTS AND METHODS 
All men participating in the study were informed about the scientific goals and therapeutic 
options related to the performance of the testicular biopsy. Also, alternative treatruent modalities 
like ICSI and donor insemination were discussed and offered, where appropriate. 
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The andrological work-up was perfonned according to the WHO manual for the investigation 
and diagnosis of the infertile couple (7). Semen analysis was perfonned twice according to WHO 
laboratory manual for the examination of human semen (8). FSH was detennined at intake. In 
men 'With a consistently low seminal volume or a history of male accessory gland infection 
transrectal ultrasound investigation of the prostate and the seminal vesicles was performed. 
Scrotal ultrasound was performed routinely to detect intrascrotal abnormalities that go 
undetected during physical examination (9). 
A bilateral excisional testicular biopsy was performed under local anaesthesia. The Jolmsen 
score was detennined of the left and right testis (3). In men with a nonnal biopsy score, scrotal 
exploration and microsurgical repair was discussed. In men with an obstruction of the ejaculatory 
ducts a trans-urethral of incision of the ducts was offered. Alternatively, couples could choose 
for ICSI if motile spenn were present in the ejaculate. The results of these treatments were 
evaluated by patient charts readings and questionnaires. 
Statistical analysis of the data was perfonned using the non-parametric Student's test, the 
Wilcoxon Rank test and Speannan' s correlation procedure, where appropriate. Two~sided p-
values less than 0.05 were considered significant. 
RESULTS 
In 78 men with less than I million spennatozoa/rul in both analyses a testicular biopsy was 
perfonned. Table I shows the results of the clinical and ultrasound investigation. A history of 
inguinal or scrotal surgery was present in 21 patients (26.9%), including 10 men vvith a history of 
cryptorchidism and orchidopexia (12.8%). 
TARLE 1: Male infertility associated factors in 78 men with severe oligozoospermia. 
Obstruction No obstruction Total(%) 
Childhood hernia repair 8 3 II (14.1%) 
Cryptorchidism/orchidopexia 5 5 10 (12.8%) 
Male accessory gland infection 5 5 10 (12.8%) 
Malignancy 3 4 7 (8.9%) 
I Chronic disease 0 3 3 (3.81 %) 
Varicocele I 8 9 (I 1.5%) 
Total 22 28 50/78 (64.1%) 
49 
i 
Male accessory gland infection was present in 10 men (12.8%), a previous testicular tumour in 4 
(5,1 %). The mean infertility duration was 2.9 years. Transrectal ultrasound was performed in 10 
patients and showed abnormal in 6: 4 patients showed a cystic lesion in the prostate midline, 2 
showed a dilatation of the seminal vesicles. Scrotal ultrasound was performed 66 men and 
showed abnormalities in 10 men, including 9 cases of varicocele and 1 testicular tumour. In men 
with a normal spermatogenesis only 1 varicocele was detected by ultrasound versus 8 varicoceles 
in men with impaired spermatogenesis. 
A normal Johnsen score (>9) was found in 14 men, a slightly disturbed spermatogenesis 
(Johnsen score 8-9) in another 25 patients. Thus, a total of39/78 (50%) patients showed a 
complete or nearly complete spermatogenesis. FSH was normal in 57 men of which 38 (66.6%) 
had a normal spermatogenesis. FSH was significantly different in men with an intact 
spermatogenesis as compared to men with impaired spermatogenesis (P<0.0001, Wilcoxon Rank 
test). Testicular volume was significantly lower in men with an abnormal spermatogenesis (mean 
13,6 cc) as compared to the testis volume of men with normal spermatogenesis (mean 16,7 cc, p 
= 0,01, Student's test). 
Trans-urethral roof resection of the midline prostatic cyst was performed in 2 patients and 
resulted in improved semen quality in 1 man, but not in a spontaneous pregnancy. A 
nticrosurgical repair of the senrinal tract (vasoepididymostomy) was performed in 9 men and 
resulted in significantly improved semen quality in 4 and spontaneous pregnancy in 2 couples. 
Alternatively, intracytoplasntic sperm injection (ICSI) was performed in 24 couples and resulted 
in 4 (16.6%) ongoing pregnancies. 
Table 2. Results of treatment in 78 men with severe oligozoospermia. 
V as<H<pididymostomy ICSI Midline prostatic cyst 
No. 9 24 2 
Obstruction 9 2 
No obstruction 0 0 
Improved sperm quality 4 I 
Pregnancy 2 416%) 0 
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DISCUSSION 
Obstructions of the male reproductive tract are usually associated with azoospermia, normal 
physical findings and normal FSH, A testicular biopsy is required to confinn the diagnosis of 
obstruction before scrotal exploration is performed. Although obstructions in primary infertile 
men are commonly present at the epididymal level, other sides of obstruction are the ejaculatory 
ducts and the vas deferens. In 20% of men with a suspected obstruction no spermatozoa are 
found in the epididymis during scrotal exploration, indicating that there is an intratesticular 
obstruction. Berardinucci et.al. reported that anatomical abnormalities are often found in men 
with suspected epididymal obstruction (6). In a series of 147 men evaluation of the reproductive 
tract resulted in 52.7% epididymal obstructions and 47.3% other anatomical abnormalities, like 
vasal obstruction and aplasia, epididymal atresia and intra-testicular obstructions. Jarvi eta/. 
detected abnormalities of the ejaculatory ducts in 33% of men with suspected epididymal 
obstruction (I 0). These abnormalities were associated with a poor outcome for 
vasoepididymostomy. 
Different classification systems for testicular biopsies have been proposed to objectively quantify 
the presence of a ductal obstruction (2, 3, 11). The mean number of mature spermatids per tubule 
correlated closely to the diagnosis of obstruction. In men with severe oligozoospermia Silber et 
a/. found that the presence of more than 20 mature spermatids per tubule indicated partial 
obstruction of the epididymis. 
Unilateral or partial obstruction of the male genital tract may be the result of childhood hernia 
repair: Matsuda eta!. investigated subfertile men with a history of hernia repair and found a 
unilatetal obstruction to be present in 26.7%. (12). A vasovasostomy procedure was performed 
in 10 men and resulted in improvement of the semen quality in 5 cases and in pregnancy in 2 
patients. Obstructive oligozoospermia was present in 61% of 60 patients, investigated by 
testicular biopsy(!). Normal spermatogenesis was found in 70.2% of men with a history of 
cryptorchidism. They concluded that in all men with oligozoospermia it is necessary to exclude a 
partial obstruction of the seminal path. The most frequent cause for this obstruction was 
epididymitis, which caused progressive deterioration of the spermiogram. 
We examined a subset of infertile men with less than 1 million spermatozoa!ml for possible 
obstruction of the male genital tract. Normal or nearly normal spermatogenesis appeared to be 
present in 50% of the patients. A history of inguinal and genital surgery and male accessory 
gland infection was present in 18/78 (23%) of the men with an obstruction. Furthermore. in 6 
men signs of an obstruction of the ejaculatory ducts were fmmd on trans-rectal ultrasound 
investigations. A normal FSH was found in 57/78 men with severe oligozoospermia and 38 
51 
(66,6%) showed to have an intact spermatogenesis, Microsurgical repair of the epididymal 
obstruction could be performed in 9 men and was successful in 4 (44.4%). 
We conclude that obstructions of the male reproductive tract are highly prevalent in men with 
severe oligozoospermia, normal testis volume and a normal FSH. A testicular biopsy and 
microsurgical repair of the seminal path should be considered in these men. 
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Abstract 
Congenital bilateral absence of the vas deferens (CBA VD) is found in 1-2% of the infertile 
males and in most male cystic fibrosis (CF) patients. CF and part of the CBA VD cases were 
found to share the same genetic background. 
In this study 21 males with CBA VD had extensive physical and laboratory testing for 
symptoms ofCF. Possible defective cellular chloride transport was measured by Interstitial 
current measurements (ICM) of rectal suction biopsies. Cystic fibrosis transmembrane 
conductance regulator (CFTR) gene mutation analysis was performed for 10 common CFTR-
mutations. 
CF-related symptoms were found in six men. On laboratory testing slightly abnormal liver 
and pancreatic function were found in seven patients. The sweat was found abnormal in four 
patients. ICM showed defective chloride excretion in 11 patients. CFTR-gene mutations were 
found in 66% of the patients: eight were compound heterozygotes; in six only one common 
mutation could be detected. The 5T allele in one copy of intron 8 was found in four men. 
CBA VD appears to be a heterogeneous clinical and genetic condition. A CFTR-gene mutation 
was found in both copies of the allele or ICM showed defective chloride excretion in 14/21 
cases. Genetic counselling is clearly indicated for couples seeking pregnancy through 
epididymal or testicular sperm aspiration and intracytoplasmic sperm injection. 
Key words: Congenital bilateral absence of the vas deferens I Cystic Fibrosis I Clinical 
Symptoms I CFTR-gene analysis I Intestinal current measurements. 
Running Title: Congenital bilateral absence of the vas deferens and cystic fibrosis. 
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Introduction 
Congenital bilateral absence of the vas deferens (CBA VD), due to bilateral regression of the 
mesonephric duct, occurs in 1-2% of infertile males and in 6% of azoospermic men (Oates 
and Amos, 1994). Clinical symptoms of CBA VD are bilateral non-palpable vas deferens, 
absence of the distal part of the epididymis and hypoplasia of the vesicula seminalis. 
Azoospermia with low semen plasma volume (<1.5 ml) and low pH (<7,5) is consistently 
found. Testis volume and serum gonadotrophins are usually normal. Testicular biopsy shows 
normal or slightly defective spermatogenesis. Viable sperms can be harvested from the 
epididymis by micropuncture (MESA) and pregnancy can be obtained by in vitro fertilisation 
(IVF) or intracytoplasmic sperm injection (ICSI, Silber eta/., 1994). 
The aetiology of CBA VD is unknown. Most male cystic fibrosis (CF) patients have CBA VD 
and it was suggested that CBA VD represents an incomplete form of CF (Holsclaw eta!., 
1971). Since the identification of the cystic fibrosis transmembrane regulator (CFTR)gene 
(Riordan eta/., 1989), mutations have been found in 62 % of cases of CBA VD (Patricio et al., 
1993; Mercier eta/., 1993; De Braekeleer and Ferec, 1996). 
CBA VD patients have been reported to cany t\vo, one or no CFTR-gene mutations, one of 
them being 'F508, the most frequent CF mutation. Recently the Rll7H mutation, a rare 
mutation in CF patients, was found to occur frequently in CBA VD patients (Gervais eta!., 
1993). Furthermore, the 5T variant of the polypyrimidine stretch in intron 8, which is thought 
to influence splicing was shown to occur more frequently in CBA VD as compared to controls 
(Chillon et al., 1995; Chu eta/., 1993). In cases where CBA VD is associated with urogenital 
malformation CFTR-gene mutations appear to be absent, suggesting a different aetiology 
(Dumur et al., 1996). 
The aim of this study was to investigate whether patients with CBA VD have other CF related 
non-genital manifestations, and if so, how to improve genetic counselling in case of demand 
for MESA/ICSI treatment. 
Materials and methods 
Patients 
This study was approved by the Hospital Medical Ethical committee and by patients by 
"Written informed consent. Twenty-one infertile patients with obstructive azoospermia due to 
bilateral absence of the scrotal vas deferens were enrolled in the study. The diagnosis was 
made by physical examination and confirmed by demonstration of azoospermia with low 
semen plasma volume and low pH. 
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Figure I. Interstitial current measurements of a rectal biopsy. 
Pos =positive, Neg = negative, I= CF response, II= low residual chloride secretion, III= 
high residual chloride secretion. 
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A medical history was obtained focused on symptoms common in CF, such as rhino-sinusitis, 
nasal polyps, obstructive lung disease, recurrent pulmonary infections, gastro-intestinal 
malabsorption, fat intolerance, oily stools, cholelithiasis, liver dysfunction and intestinal 
obstruction. Family history was documented for CF and other genetic abnormalities. 
Physical examination 
Physical examination included urogenital and pulmonary investigation and measurement of 
weight, height and nutritional state. Pulmonary function tests included forced vital capacity 
(FVC) and forced expiratory volume in l s (FEV1). A chest X-ray was performed. The 
Shwachman score was determined for all patients (Shwachman, 1990). Sonography of the 
kidneys and transrectal ultrasound was performed to detect urogenital malformations. 
Laboratory testing 
Laboratory testing included bacterial cultures in sputum, measurements of gonadotrophins 
[Luteinizing hormone (LH) and follicle-stimulating hormone(FSH)], liver function, serum 
glucose level and faecal chymotrypsin. Bilateral Sweat tests were performed and, in the 
absence of normal values for adults, judged as abnormal if chloride > 50 mmol/1. 
Electrophysiological study 
Interstitial current measurements (ICM) on rectal tissue were performed (Veeze et a/.,14). 
Rectal suction biopsies were mounted in an Ussing chamber with an exposed area of 1.13 
mm2. Sodium channels were blocked by adding amiloride (l 0-4 mol/l). Endogenous prostag-
landin synthesis that is possibly linked to cAMP-mediated chloride secretion was inhibited by 
adding indomethacin (10'5 moVl). Carbachol (104 mol/l) was added for cholinergic activation 
of chloride secretion. 
In healthy controls, a carbachol-provoked change in ICM values was found (Control, Fig I). 
The inward current in controls reflects transcellular chloride transport (serosa to mucosa) 
through the Na-K-Cl co-transporter in the basolatera! membrane and the CFTR-chloride 
channel in the apical membrane. In the majority of CF patients a carbachol induced outward 
current response (Type I negative, fig 1) occurs. This reversed response probably results from 
apical potassium secretion that is unmasked in the case of absent or largely reduced chloride 
secretion. 
In a subclass of CF patients, usually after a negative peak response, a separate and small 
positive peak response was observed, the result oflow residual chloride secretion (Type II, 
fig.!). In another subset of cases a high residual chloride secretion was seen (type III, fig.!), 
due to chloride excretion by non-CFTR channels. The amount of residual chloride secretion 
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appeared to correlate with preserved pancreatic function and delayed presentation of the 
disease, which was not exclusively determined by the CF genotype (Veeze et a/.,1994). 
ICM is especially indicated in individuals with borderline or high normal sweat test results 
and an inconclusive CFTR mutation analysis, who can otheiVIise not be distinguished from 
CF-carriers. 
DNA analysis 
DNA was isolated from peripheralleucocytes. CFTR mutation analysis was performed for I 0 
mutations: we analyzed for the mutations Rll7H, A455E, 'F508. 1717-IG->A, G542X, 
R553X, Rll62X, S!251N, Wl282X, and N!303K. The length of the T-stretch in intron 8 
was determined (Kiesewetter et a/.,1993). Only the allele specific oligonucleotide for the 
identification of the 9 T-sttetch was changed into: 5e- lGTGTG TTT TTT TTT AAC AG-3e, 
using a hybridization temperature of 3 7° C for all allele specific oligonucleotides. 
Results 
Table I summarizes the abnormal physical and laboratory findings. The history revealed nasal 
polyps/rhino-sinusitis (n~3), obstructive lung disease (n~l) and fatty stools (n~2). Two 
patients had a positive family history for CF. Pulmonary function was abnormal in I case with 
a history of pertussis in childhood: on chest X-ray atelectasis and bronchiectasis were found. 
The Shwachman score was abnormal in one (80) and borderline (95) in another case. 
High gamma GT, not related to alcohol consumption was found in 6 cases. Faecal 
chymotrypsin was low in 4 cases, indicating exocrine pancreatic dysfunction. In 4 cases the 
sweat test was borderline by using strict criteria. 
ICM showed either a typical CF-response (fig I, type I) (n~), a low residual chloride 
excretion (fig I, type Il)(n~l) or a high residual secretion (fig I, type III)(n~6). The test was 
found inconclusive in 1 case and normal (fig 1, control) in 10 patients. 
CFTR-gene analysis showed 1 or 2 mutations in 14/21 cases. In 8 patients tvvo different 
mutations (compound heterozygosity) were found. in 6 patients only I mutation could be 
identified. In 7 cases no common CFTR-gene mutation could be detected: 4/7 of these were 
non-Caucasians. A 5T allele in one copy of the CFTR gene was found in 4 cases, 3 times in 
combination with a mutation in the other allele. 
The "F508 mutation was found in 8 patients, Rll7H in 6, A445E in 3 and 1717-IG->A and 
R553X both in one. Three partners were found to have a single CFTR-gene mutation (Rll7H. 
Rll7H, 'F508). 
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Case no. Age History tests Laboratory Sweat ICM CFTR mutations T-stretch Remarks " 
"'" (years) Cl-JNa+ test intron 8 ;'
~ 
1 36 NA NA 38/46 CF response (I) LIF508/Rll7H 917 Non-Caucasian 
"' 2 27 Sinusitis/fat intol. Chymotr.< 23/22 CF response (I) LIF508/Rll7H 917 CF in family ~ 3 33 CARNoily stools Ggt> ,Chymotr. < 23/36 CF response (I) LIF508/- 917 
4 31 Pelvic re kidney NA l0/22 CF response (I) -1- 717 ~ 
5 32 Sinusitis/nasal Chymotr.< 50/52 CF low residual (II) A455Ei- 9/5 Partner ~dF508 0 
polyps 
...., 
"" 6 38 NA NA 40/43 CF high residual (Ill) A445EIR 117H 917 ~ 7 27 NA Ggt> ,Chymotr. < 28/44 CF high residual (Ill) R ll7H/R553X 717 Partner R117H (;" 
8 38 Nasal polyps ~A 34/51 CF high residual (ill) LIF508/Rll7H 917 Pertussis ec 
9 36 NA NA 58/70 CF high residual (lll) LIF508/- 9/5 !l 
lO 31 NA Ggt> 54/70 CF high residual (Ill) LIF508/- 9/5 Partner Rll7H p. 
ll 32 Maldescended Ggt> 16/34 CF high residual (ill) -1- 917 Single kidney in family g: 
testis 0 
12 35 NA NA 14/21 Inconclusive LIF508/- 9/7 ~ 
13 29 NA NA 43/70 Normal response (IV) A455E!Rll7H 9/7 <';! 
., 14 38 NA NA 32/55 Nom1al response (IV) Rll7H/1717-1->G->A 717 5' 0 15 29 NA Ggt> 44/66 Nonnal response (IV) LIF508/R 117H 917 p. 
16 28 NA NA 42/48 Nom1al response (IV) Rll7H/- 717 :r 
17 36 NA NA 22/44 Normal response (IV) -1- 7/5 Non~Caucasian oq ~ 
18 34 NA NA 57/30 Nomtal response (IV) -I- 717 Non-Caucasian s· 
19 39 NA NA 36/52 Nonnal response (IV) -1- 717 Non-Caucasian 
"" 
" 20 31 NA NA 16/30 Normal response (IV) -/- 717 Non-Caucasian "'· 
" 21 34 NA NA 20/41 Normal response (IV) -/- 717 s 
~ 
NA = no abnonnalities, GgT = gamma glutamyl transpeptidase, Chymotr. = chymotrypsin, ICM = interstitial current measurement (see Figure 1), CFfR = ~-8" 
cystic fibrosis transmembrane conductance regulator gene, -: none of lO CF mutations, T-strctch = polypyrimidine (T) stretch intron 8. () 
Shwachman score was 95 in case I and 80 in case 8. Physical examination showed bronchiectasi!l in case 8 and hypogonadism in case 19. OJ ;,. 
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Discussion 
The observation that the vas deferens is absent in almost all male CF patients suggested that 
CBA VD is a primary genital form ofCF (Holsclaw et al., 1971). Since the identification of 
the CFTR-gene, CBA VD and CF were often found to share the same genetic background 
(Patricio et al., 1993; Mercier et al., 1993). CFTR, the product of the CFTR-gene, a cell 
membrane protein of 1480 amino-acids regulates transmembrane chloride transport. Over 750 
mutations of the CFTR-gene have been raported, OF508 being the most frequent mutation in 
CF patients. CF is an autosomal recessive disease; a patient with CF receives two defective 
alleles. The carrier risk in caucasians is 1 :25. 
In CF conductive chloride transport is defective in epithelial tissues, resulting in viscous 
secretions associated with pulmonary infections, malabsorption and intestinal obstruction. The 
severity of the disease varies widely: homozygosity for the 'F508 mutation was found to 
correlate with pancreatic insufficiency, early manifestations, poor lung function and high 
mortality (Kerem et al., 1990). Other mutations, like Rll7H, are associated with a milder 
form of CF where conductive chloride transport is defective, but not absent (Gervais et al., 
1993). 
The CFTR-gene mutations occur frequently in CBA VD (Oates aud Amos, 1994; Patricio et 
al., 1993; de Braekeleer et al., 1996), but the molecular basis ofCBA VD is not completely 
llllderstood. Mutations with a low frequency in classic CF, like R117H, were follild to occur 
regularly in CBA VD (Gervais et al., 1993). Homozygosity for 'F508 or compound 
heterozygosity for 2 severe mutations was not found in cases ofCBA VD. It has been sugge-
sted that CBA VD patients are compound heterozygotes for a severe mutation on one allele in 
combination with a mild CFTR gene mutation on the other allele. In the majority of cases, 
however, only one CFTR-gene mutation could be detected in CBA VD. Recently alterations in 
the non-coding regions of the gene, such as the polypyrimidine stretch in intron 8, in 
combination with a mutation in the other allele, were found to cause abnormal levels of 
CFTR-protein (Chu et al., 1993). Impaired CFTR-protein function may cause defective, but 
not absent chloride excretion resulting in absence of the vas deferens, but not in pulmonary or 
pancreatic insufficiency (Angniano et al., 1992). The epididymis may be more susceptible to 
defective chloride transport, resulting in an early regression of the mesonephric duct. In 
contrast, only 6% ofCFTR-protein function is necessary for normal pancreatic function 
(Tizzano et al., 1994). Also, the wide variability of symptoms related to various combinations 
of CFTR-mutations suggests a possible role for unlinked genetic factors in the expression of 
these mutations. 
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In this study 21 patients with CBA VD were investigated for non-genital manifestations of CF: 
in 6 patients mild CF symptoms were present. Slightly abnormal liver and pancreatic function 
were detected in 7, sweat tests showed high levels of chloride in 4 patients. Electrophysiology 
of rectal suction biopsies, not previously performed in CBA VD, showed defective chloride 
excretion in 11 patients. Three of these patients showed very low sweat test results, indicating 
different tissue expression of impaired CFTR function. 
CBA VD appears to be a heterogenous clinical and genetic condition: 2 CFTR gene mutations 
were detected in 8 patients, 5 of them showing CF characteristics on ICM. In these men the 
CBA VD might represent a mild form ofCF. Of the patients carrying a single CFTR mutation 
4 also showed defective chloride excretion on ICM, suggesting mutations going undetected 
with the cmrent screening technology. So far no convincing evidence has been brought 
forward that the presence of a single CFTR mutation (i.e. simple hetrozygosity) has any 
phenotypic consequences (Meschede et a!., 1997). Therefore. in case of CBA VD and 
defective chloride excretion further analysis of the CFTR gene is required to detect rare 
variant mutations. 
In most cases of CBA VD residual or normal chloride excretion was found in combination 
with either an abnormal sweat test or CFTR-gene mutations. Only in 5 cases ofCBA VD no 
abnormalities could be found, 4 of these men being non-caucasians. These results suggests 
that there is a wide spectrum of phenotypical expressions of cystic fibrosis, with pancreatic 
and puhnonary insufficiency on the one end and CBA VD on the other end of the spectrum. 
Since the introduction of microsurgical epididymal sperm aspiration and intracytoplasmic 
sperm injection (Silber eta!., 1994) infertility due to CBAVD was treated successfully 
resulting in ongoing pregnancy. Biological parenthood is now a realistic option for males with 
CBA VD, producing ongoing pregnancies in 20- 30% of cases (Dohle et al., 1998). 
For couples with CBA VD-related infertility CFTR mutation analysis and genetic counselling 
of the patient and his partner is essential before MESA/ICSI procedures are performed (Pauer 
et al., 1997). Although the apriori carrier risk for a CFTR-gene mutations is only 3-4%, three 
partners of the male CBA VD group had a single CFTR-gene mutation. In these cases the risk 
of offspring with a (mild or severe) form of CF could be 50%. 
As there is no straightforward relation between the genotype and the phenotype for most 
CFTR-gene mutations, genetic counselling in these situations is complex, as no precise 
predictions on rare compound phenotypes of CF are possible. Considering all the medical and 
psychological burdens ofMESA/ICSI procedures, followed up by chorionic biopsy for early 
prenatal diagnosis of CF, reproduction becomes complicated for these couples. Pre-implan-
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tation screening of embryos would be an alternative teclmique for prenatal diagnosis) but does 
not solve all ethical problems. In case of a CFTR mutation in the partner and no detectable 
mutation in the CBA VD male, a positive ICM test in the patient will indicate rare variant 
alleles of the CF gene. However, if no CFTR-gene mutations are found in the female partner, 
the risk of offspring with CF is at the most 1 :400. Pre-natal or pre-implantation screening for 
CF is not possible in these cases. 
In conclusion, CBA VD appears to be a heterogeneous condition with respect to CF 
symptoms, tissue expression of defective chloride excretion and CFTR gene mutation 
analysis. Only in a small subset of men with CBA VD no abnormalities could be detected. 
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Abstract 
Male infertility due to severe oligozoospermia and azoospermia has been associated with a 
number of genetic risk factors. In this study 150 men from couples who applied for 
intracytoplasmic sperm injection (ICSI) were investigated for genetic abnormalities, such as 
constitutive chromosome abnormalities, microdeletions of theY chromosome (AZF region) and 
mutations in the cystic fibrosis transmembrane conductance regulator ( CFTR) gene. 
A male infertility associated factor was found in 63/150 ( 42%) men, including a history of 
cryptorchidism (13.3%), varicocele (10.0%), male accessory gland infection (5.3%) and 
congenital vas deferens abnormality (4.0%). Genetic analysis identified 16/150 (10.6%) 
abnormal karyotypes, 8/150 (5.3%) AZFc deletions and 14/150 (9.3%) CFTR gene 
mutations. An abnormal karyotype was found both in men v.rith oligozoospermia and 
azoospermia: 9 men had a sex-chromosomal aneuploidy, 6 translocations were identified and 
one marker chromosome was found. Six Klinefelter· s patients ( 4 7 ,)CXY) showed 
hypogonadism and azoospermia or occasionally a non-motile spermatozoa in the ejaculate. 
FSH was high in all Klinefelter patients. In patients with a translocation no specific 
abnormalities were found on andrological evaluation: all men showed oligozoospermia and a 
normal or slightly elevated FSH. 
Y chromosomal microdeletions were mainly associated with male infertility, due to testicular 
insufficiency. All deletions identified comprised the AZFc region, containing the Deleted in 
Azoospermia (DAZ) gene. CFTR gene mutations were commonly seen in men with 
congenital absence of the vas deferens, but also in 16% of men with azoospermia without any 
apparent abnormality of the vas deferens. 
A genetic abnormality was identified in 36/150 (24%) men with extreme oligozoospermia and 
azoospermia. Excluding those with a congenital abnormality of the vas deferens (N=6) a genetic 
risk factor was found in 20/113 (17.6%) men with oligozoospernlia and in 11132 (34%) men with 
azoospermia. Two men showed to have 2 genetic risk factors: 1 Klinefelter patient also carried a 
CFTR gene mutation (Rll7H), another man was found to have both an AZFc deletion and a 
CFTR gene mutation ( 'F508). Application of!CSI in these couples can result in offspring with 
an enhanced risk for unbalanced chromosome complement, male infertility due to the 
transntission of a Y-chromosomal nticrodeletion, and cystic fibrosis if both partuers are CFTR 
gene mutation carriers. Genetic testing and counselling is clearly indicated in these couples 
before ICSI is considered. 
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Introduction 
Male infertility has been associated with several genetic and non~genetic conditions, like 
hypogonadotrophic hypogonadism, testicular maldescent, structural abnormalities of the male 
genital tract, genital infections, previous scrotal or inguinal surgery. varicoceles, chronic illness, 
medication and exposure to chemicals. In at least 40% of men no cause of the infertility was 
found (Unexplained infertility, E.S.R.H.E., 1992). Genetic abnormalities were identified in men 
v.rith unexplained oligozoospermia and azoospermia, including numerical and structural 
chromosomal abnormalities (Chandley eta/., 1998), deletions of the Azoospermia factor region 
of theY chromosome (AZF , Vogt et al .. 1996, Reijo eta/., 1995) and mutations in the cystic 
fibrosis transmembrane conductance regulator ( CFTR) gene, commonly associated with 
congenital vas deferens abnormalities (Jaffe eta!., 1994, Doble eta!., 1999). Most numerical 
chromosome abnormalities and AZF deletions are de novo events in the parental germ cells. 
Some abnormalities associated with infertility are inherited, like reciprocal and Robertsonian 
translocations and CFTR mutations (Mak et a!., 1996). 
ICSI is the most significant recent development in the treatment of male infertility, enabling 
couples who were previously deemed infertile to produce offspring, however, with the risk of 
passing on genetic abnormalities, and possibly decreased fertility. To assess the couple"s risk 
for transmitting a genetic abnormality we analysed the results of a combined and.rological. 
cytogenetic and molecular genetic screening of 150 men, with oligozoospermia and 
azoospermia. We discuss the necessity of genetic counselling for these infertile couples. 
Patients and methods 
For this study men were selected with an infertility duration of at least one year and a semen 
analysis, showing less than 1 million motile spermatozoa /rnl. History taking was focused on 
urogenital development, chronic illness, pulmonary diseases, growth disturbances, medication, 
male accessory gland infections (MAGI), previous inguinal and scrotal surgery and occupational 
exposure to heat or chemicals. All men were investigated for genital malformations and 
ultrasound investigation of the scrotal content was performed. 
Semen analysis was performed twice according to the \VHO guidelines for semen analysis 
(Rowe eta/., 1992) with an interval of at least one month. Laboratory investigations included 
serum gonadotrophins, testosterone, prolactin and sex hormone binding globulin. 
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Cytogenetic analysis was performed on metaphase spreads of cultured lymphocytes. 
Fluorescence in situ hybridization (FISH) was applied in case I 0 according to Kievits eta/. 
(Kievits eta/., 1990) with the probes cp9-23.1 and pDP! OS, specific for the X andY 
chromosome short arm telomere regions, and the testis determing region of theY 
chromosome, respectively. 
DNA was extracted according to standard procedure and the presence of sub-microscopic 
deletions of the AZF region on theY chromosome long ann was analysed using a multiplex 
PCR for Y-specific markers, including DYS148 and DYS 273 (AZFa), DYS218 and DYS224 
(AZFb), SY245 and SY255 (DAZ gene, AZFc region). These STS were chosen based on the 
laboratory guidelines described by Simoni eta/. (Simoni eta/., 1999) 
Twelve conunon mutations of the CFTR gene were tested ( 'F508, A445E, G542X, 
1717-IG->A, R553X, Rl17H, Rl162X, Nl303K, Wl282X, 3659de!C, E60X, Sl251N). The 
mutations tested comprise about 85% of the mutations identified in the Dutch Caucasian CF 
population. The length of the T-stretch in intron 8 was tested as previously described (Dohle 
et al. 1999). 
Results 
Genetic testing was performed on 37 men with azoospermia (24.7%) and 113 with severe 
oligozoospermia (75.3%). Table I shows the results of the andrological evaluation. A testicular 
tumour was found in 2 cases. In 56.6% of the andrological evaluations no male infertility 
associated factor was identified. 
Table 2 shows 38 genetic abnormalities identified in 36 patients. Cytogenetic analysis showed an 
abnormal results in 16 (10.6 %) patients. A sex-chromosomal aneuploidy was identified in 9 
men. The Klinefelter syndrome (47,XXY) was present in 6 patients, of which 3 with 
azoospermia and 3 \\!ith an occasional non-motile sperm in the ejaculate ( cryptozoospermia). 
One patient presented a 46,XX karyotype, withY -short arm DNA sequences present in one of 
the X chromosomes short arms. FSH was high (>7 ill/ml) in all men with a 47,XXY karyotype 
and in the 46,XX male. One Klinefelter patient (case nr.S) also carried a CFTR gene mutation 
(Rll7H). Six balanced translocations and one marker chromosome were found in men with 
oligozoospermia and a normal phenotype. FSH was either normal or slightly elevated, 
oligozoospermia was present in all translocations. 
Analysis of the AZF-a,-b and -c regions of theY chromosome identified 8 (5.3%) men with an 
AZFc (DAZ) deletion, 5 with severe oligozoospermia and 3 with azoospermia. A normal 
testicular volume was present in 5 men and FSH was increased in 3. Six men with an Yq 11 
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rnicrodeletion had unexplained male infertility, one man (case nr. 2) also carried a CFTR gene 
mutation ( "F508). 
CFTR gene mutations were identified in 14/150 (9.3.%) patients, associated with congenital 
abnormalities of the vas deferens in 4 cases. All CBA VD patients showed low volume (<1,0 
ml) and low pH ( <7,0) semen analysis and azoospermia and had normal abdominal ultrasound 
investigations. In 2 patients the scrotal vas deferens was present, but on vasography a blind 
ending was visualised in the distal part of the vas deferens. Both men also had low semen 
volume, low pH and azoospermia. A single CFTR gene mutation was identified in one. Six 
(16%) men with azoospermia but without an apparent congenital abnormality of the vas 
deferens showed a single CFTR mutation. In 5/113 (4.4%) patients with severe 
oligozoospermia a single CFTR mutation was identified. 
A genetic abnormality was present in 36/150 (24.0%) men with severe oligozoospermia and 
azoospermia. Excluding those with a congenital abnormality of the vas deferens a genetic risk 
factor was present in 11/32 (34%) of men with azoospermia. In men with extreme 
oligozoospenmia a genetic abnormality was identified in 20/113 (17.6%). Two patients carried 
two risk factors: 1 Klinefelter patient ( 4 7 ,)OCY) also carried a Rll7H mutation in the CFTR 
gene, another man was found to have both an AZFc deletion of theY chromosome and a 'F508 
CFTR gene mutation. 
Discussion 
Genetic counselling in reproductive medicine starts by obtaining an accurate diagnosis. The 
family history, physical examination (including evaluation of dysmorphology) and various 
laboratory tests on both partners are generally required (Rowe eta/., 1993). A substantial 
number of infertile men) however, present without a history associated with fertility problems 
and have normal findings on physical examination and endocrine laboratory testing. Only semen 
analysis is abnormal, often showing a decreased number of sperm cells (oligozoospermia), 
decreased sperm motility ( asthenozoospenmia), and many abnormal forms on morphological 
examination (teratozoospermia). Combinations of these abnormalities occur frequently and are 
described as the OAT ( oligo-astheno-teratozoospenmia) -syndrome. These idiopathic forms of 
male subfertility may be explained by factors like endocrine disruption due to environmental 
pollution, reactive oxygen species and genetic abnormalities (E.S.R.H.E., 1992). Although 
infertility associated with chromosome abnormalities has long been recognised, the introduction 
of intracytoplasmic sperm injection (ICSI) as a method to overcome severe spermatogenic 
defects has stimulated many investigators to further explore the genetic basis of male infertility. 
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In this study we confirmed that male infertility, both with and without a detectable cause, was 
associated with several genetic risk factors such as constitutional chromosome abnormalities, 
rnicrodeletions of the Y chromosome and mutations in the CFTR gene. 
An abnormal karyotype was found in 10.6% of the men with severe oligozoospermia or 
azoospermia. In a recent review (van Assche et a/.,1996) the frequency of karyotypic abnormali-
ties in 1701 males with infertility was found to be as high as 13.7% in azoospermia and 4.6% in 
oligozoospermia. Numerical sex chromosomal abnormalities, present in 63% of all cytogenetic 
abnormalities in infertile males, were commonly found together with azoospermia. Autosomal 
anomalies, like Robertsonian and reciprocal translocations and inversions were usually present in 
men with oligozoosPermia. In the Klinefelter syndrome the extra X chromosome was associated 
with germ cell atresia, whereas in the other cytogenetic abnonnalities no specific relation to 
meiotic disturbances was found as these abnormalities also occurred in men with normal 
spermatogenesis. 
In this study DNA-analysis of the AZF-a,-b and -c regions on theY chromosome showed 
deletions in 5.3% of the patients. All deletions identified comprised the A.ZFc region, containing 
the Deleted in Azoospermia (DAZ) gene (Reijo et al..l995). TheY chromosomal nticrodeletions 
are the most common genetic causes of male infertility due to spermatogenic failure and have 
been reported in 3-21% of the infertile men (van der Yen et al., 1997). These nticrodeletions 
were associated with severe oligozoospermia and non-obstructive azoospermia, normal physical 
findings and normal concentrations of gonadotrophins. Histological studies of testicular biopsies 
from men carrying an AZF deletion exhibit a wide spectrum of spermatogenetic defects from 
complete absence of germ cells (Sertoli-cell-only syndrome) to maturation arrest with occasional 
production of mature, condensed spermatids (Reijo eta/., 1995). 
Men with defects of the Wolffian duct, presenting as congenital bilateral absence of the vas 
deferens, were fmmd to carry different mutations of the cystic fibrosis transmembrane 
conductance regulator gene (Oates eta/., 1994, Jaffe eta/., 1994). CBA VD, previously 
described as a genital form of cystic fibrosis ( CF) appears to be a heterogeneous clinical and 
genetic condition. We have sho\Vll that some patients with CBA VD also have non-genital 
symptoms of CF, like defective cellular chloride excretion and disturbed pancreatic function 
(Dohle eta/., 1999). It has been suggested that CBA VD patients are compound heterozygotes 
for a severe mutation in one allele in combination with a mild CFTR gene mutation in the 
other. Alterations in the non-coding regions of the gene, such as the polypyrimidine stretch in 
intron 8, in combination with a mutation in the other allele, were found to cause abnormal 
levels of CFTR-protein, due to exon 9 skipping translation (Chu eta!., 1993). CFTR intron 8 
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DNA variants may alter the splicing efficiency of the CFTR mRNA in exon 9 (Kiesewetter et 
a!., 1993), thus causing reduced concentrations of CFTR protein (Chill on eta/., 1995). 
Impaired CFTR-protein function may cause defective, but not absent chloride excretion resul-
ting in absence of the vas deferens, but not in pulmonary or pancreatic insufficiency 
(Anguiano eta/., 1992). Mutations of the CFTR gene are commonly associated with 
obstructions of the male genital tract (Mak eta/., 2000). We detected at least one CFTR 
mutation in 4/6 men with CBA VD and in 10/144 men without a vas deferens-related problem. 
This seems to confirm the association of mutations in the CFTR gene with obstruction of the 
male genital tract rather than with primary testicular failure, although recently some men \Vith 
CBAVD were found to have a defective spermatogenesis (Meng et al., 2001). However, the 
rate of mutations detected in this study in the non-obstructed group does seem elevated 
compared with the carrier risk in the Dutch population of I :30 (De Vries eta/., 1997). This 
prompted us to initiate an extended study with a larger cohort of patients. Since we tested for 
mutations that are common among CF patients previously, we are now using extensive 
screening methods to evaluate the true rate of CFTR mutations/variants in this group of 
infertile men. 
In this study 38 genetic abnormalities were identified in 36 men from a population of !50 men 
with severe male infertilty. The application of!CSI in these couples may lead to offspring with 
an enhanced risk of unbalanced chromosome complement, male infertility due to transmission of 
an AZF deletion and cystic fibrosis in case of CF -related genital abnormalities. We conclude that 
all men "With severe oligozoospermia and azoospennia should be offered genetic testing and 
counselling before assisted reproduction is applied. 
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Table 1. Male infertility associated factors in !50 men with oligozoospermia and azoospermia. 
Male infertility associated factor }J (%) Genetic abnormality(%) 
Cryptorchidism 23 (13.3%) 5 (21.7%) 
Varicocele 15 (10.0%) 3 (20.0%) 
Congenital abnonnality of the vas deferens 6 (4.0%) 4 (66.6%) 
Male accessory gland infection 8 (5.3%) ! 0 
! Endocrine abnormality 3 (2%) 
! 
0 
Chronic illness 4 (2.6%) 0 
I Malignancy 2 (1.3%) 0 
I 
1 Previous inguinal and scrotal surgery 4 (2.6%) 0 
! Unexplained male infertility 85 (56.6%) 27 (31.7%) 
l 
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Table 2: Genetic abnormalities in 36 men with severe oligozoospermia and azoospermia. 
Abnormal karyotype 
Nr Genetic abnormality Medical history 'Physical Semen analysis IFSH· Remarks 
' 
examination 
' 
1 47,XXY No abnormalities Hypogonadism Cryptozoospermia 0' _, 
---
Gynaecomastia Hypogonadism -~ 2 47,XXY Cryptozoospcrmia 
-- ------3 47.XXY 1 Delayed puberty Hypogonadism Cryptozoospermia 25 
__ ,, __ 
-·-· 
____ , -
·-· ·-
4 47.XXY i Cryptorchidism Varicocele A.zoospcrmia 22 
5 47.XXY ·=- Hypogonadism A.zoospcrmia 
-- t-n--Normal 
-------
6 47.XXY ~ormal Hypogonadism A.zoospennia 11.0 CFTR: R117H 
7 47,)(YY Normal 1 Hypogonadism OAT 12 
8 47,)(YY Normal 
., 
Hypogonadism OAT 
9 C;j:;J<x ISH(cp9-23.1 ~:pDp105+) Delayed puberty i Hypogonadism Azoospermia 33 
-~, i---
' 10 i 46,XY,t(4:5)(q32:q14) Normal ~ormal OAT 7.6 
_, __ ,_..,: __ , __ 
.. 
_ _______ ,_,_ 
11 45,XY,der( 13: 15)( q 1 O:q 1 0) Diabetes mellitus ::\ormal OAT '1'4.0 
.. 
-
12 45.XY.t(l4:22)(ql 1:p?) Cryptorchidism Hypogonadism OAT 9.6 
-- iNo~l 13 46,X. t(Y:2)(q11.22:q34) Varicocele OAT 1.9 
14 45,XY.der(13:14)( q 1 O:q 1 0) :Normal Normal OAT'' 7.7 
-- -~rffia! 15 46.XY, t( 4: 15)(p 16:q22.2) varicocele OAT 6.0 L.:_ ______ 
16 47,XY .+Mar(mat='iso(l5p J) C"rogenital abn. .... Varicocele !OAT 6.4 
Deletion of the Azoospermia factor (AZF) region 
Nr 1 Genetic abnormality 1 Medical history Physical examination Semen analysis FSH Remarks 
I AZFe 
--
2 AZFc 
--·-··-
___________ , __ 
3 AZFc 
-----
4 AZFe 
5 AZFc 
6 1-AzFc 
7 i AZFc 
-s-1 AZFc·-· 
:Xormal 
Normal 
Normal 
Normal 
·-··--
Normal 
Cryptorchidism 
Normal 
Normal 
Normal OAT 2.8 
.. 
Hypogonadism OAT 7.3 CFTR: "F508/-
_,_, ___ 
·---·--
Normal OAT ! 1.0 
--- L--!----------
Varicocele OAT 6.0 
·--·----~ 
__ ,_, __ I_ 
Hypogonadism Cryptozoospermia-- 8.0 
!Normal 
f :\ormal 
Hypogonadism 
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l Azoospermia 
Azoosperm1a 
Azoospermia 
6.1 
. 
14.8 
Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations 
~r CFTR mutation 1 T-Stretch Medical history :Physical 1 Semen analysis FSH I Remarks 
examination 
1 R1171V- 7T!- Sinusitis CBAVD Azoospermia 2.3 ' 
"F508/- 5T/9T Normal CBAVD 
-- 4.6 i ·----~ 2 Azoospermia 
3 ·psos/Rll7H 7T/9T Normal CBAVD Azoospermia 14.9 [ 
--·-
Partial c8J;5ro- " ·-··-4 AMSE/- -· 5T/9T Ejaculatory failure AzoOSj)Crffii---a-! 3.3 -r-·-· 
I 
-- ·---------·-
5 E60X/- 7T/7T MAGI Normal OAT i 2.5 
=c--· -~ 6 RII7w::----- 7T/7T i l;rcthral valves Varicocele OAT 
7 ·.F5o~-- IT/9T ~-Norma1 Normal OAT 2.8 
8 ·psos/- 7T/9T !-Cryptorchidism ~ormal OAT 16.0 ··-
' 
9 ·p5os1- 7T/9T -1 - Hypogonadism OAT 7.3 1 Normal AZFc deletion 
10 "R111H1---- 7T~~Normal Hypogonadism Azoospermia 11.0 47.XXY karyotype 
---·-·--------· -~-Normal AzoO.SJ;Crmia -------·-·-··-11 ·p5os1- 7T/9T Normal 3.2 
I 
To:O --------12 ·p5os1- 9T/9T ! Cryptorchidism Normal Azoospermia 
----
13 ·psos/- 7TI7T Normal Normal 20.0 Azoospermia 
-- ~Normal 13.2 14 ·p5os1- 7T/7T Kormal Azoospermia 
CBA VD ==congenital bilateral absence of the vas deferens. 11AGI =male accessory gland infection. 
OAT = oligo-.asthcno-tcratozoospermia. FSH == follicle-stimulating hormone. AZF =azoospermia factor (Y q 11) 
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Abstract 
We evaluated the efficacy of transurethral deroofing of a midline prostatic cyst in subfertile 
men with one or more of the following semen abnormalities: decreased ejaculatory volume, 
decreased sperm motility and oligo- or azoospermia. Results of treatment of a series of 11 
subfertile men with a midline prostatic cyst are presented. 
Five patients showed an improvement of seminal volume. Only one demonstrated an 
improvement of sperm count. Sperm motility was not influenced. No relation was found 
between positive outcome following operation and either size of the cyst or dilatation of the 
seminal vesicles. Spontaneous pregnancies did not occur after transurthral deroofmg of the 
midline prostatic cyst. 
In conclusion, our study suggests a poor efficacy of transurethral deroofing of a midline 
prostatic cyst in subfertile men with the above mentioned semen abnormalities. 
KEY WORDS: MALE SUBFERTILITY- PROSTATIC CYST- TRANSURETHRAL 
DEROOFING. 
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INTRODUCTION 
In the last decade refinements of assisted reproductive techniques have gained importance in 
the treatment of male subfertility. Due to the success of assisted male reproductive techniques, 
irrespective of the aetiology of male subfertility, appropriate evaluation is often bypassed 
although several causes can be effectively treated. In abnost half of the infertile couples, male 
subfertility, defined as the failure to induce a pregnancy within one year of regulat 
unprotected intercourse (Meuleman, 1998), is present (Mosher and Pratt, 1991). It is therefore 
of importance to identify those subfertile males for whom treatment options are available 
before embarking on expensive and potentially hazardous assisted reproductive techniques. 
Ejaculatory duct obstruction (EDO) is regarded as one of the treatable causes of male 
subfertility. EDO is found in 7-14% of the subfertile male population and can be congenital or 
acquired (Goldwasser eta!., 1985; Pryor and Hendry, 1991). Normal hormone status and one 
or more of the following distinct semen abnormalities such as low or absent fructose, 
decreased sperm motility, decreased ejaculatory volume and oligo- or azoospermia are 
suggestive for total or partial EDO. The diagnosis ofEDO can be confmned directly by 
vasography (Banner and Hassler, 1978) or indirectly by transrectal ultrasonography (TRUS) 
(Jarrow, 1993). Due to its non-invasive nature TRUS is currently the diagnostic method of 
chaise. 
Theoretically, a midline prostatic cyst can be one of the causes ofEDO. The cyst, localized in 
the central zone of the prostate, can compress or displace the ejaculatory ducts to the lateral 
side (Fisch, I 992). It has been our policy to offer transurethral deroofing of prostatic cyst to 
subfertile men with one or more of the following semen abnormalities: decreased seminal 
volume, decreased motility, oligozoospermia or azoospermia, in order to improve semen 
quantity and quality and pregnancy rate. In this retrospective study we evaluated the efficacy 
of this treatment. 
MATERIAL k'ID METHODS 
Since 1996 11 patients who presented in our departments with subfertility were diagnosed 
with a median prostatic cyst. Age ranged from 25-39 years, mean 34 years. There were no 
urological complaints. Infertility was primary in I 0 patients and one patient developed 
azoospermia after fathering one son. At physical examination all patients had normal sized 
testes (15-25 ml), bilateral palpable vas deferens and absence ofvaricoceles. Follicle 
stimulating hormone and testosterone were measured and always normal. Semen analyses was 
performed at least twice before operation. Patients were asked to abstain from sexual activity 
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for 2-3 days before semen collection. Semen evaluation was performed at the university-based 
andrology laboratory and included ejaculate volume, seminal plasma pH, sperm 
concentration, percentage of sperm motility and sperm viability. TRUS of the prostate, 
performed ifEDO was suspected, demonstrated the presence of a midline prostatic cyst and, 
if present, concurrent dilatation of seminal vesicles or ejaculatory duct. 
The diagnosis of subfertility based on a median prostatic cyst was based on semen analysis 
with one or more of the following findings in addition to normal physical examination and 
normal FSH and testosterone: (i) low ejaculate volume (<2ml) azoospermia; (ii) low or 
nonnal ejaculate volume with a sperm concentration <20 million/ml; or (iii) low or normal 
ejacualte volume with sperm motility< 30% (Kim et al., 1997). 
Transurethral incision of the midline cyst was performed under local anaesthesia with the 
patient in lithotomy position. The roof of the cyst was incised under TRUS guidance and 
under direct vision through a Collins hook (Karl Storz GmbH and Co., Tuttingen. Germany). 
Generally, the prostatic floor had to be incised between the bladder neck and the 
verumontanum that resulted in complete marsupilization of the cyst. Minimal coagulation was 
used. A Ch 16 transurethral catheter (Bardex I>C>; Bard Benelux n.v., Olen, Belgium) was 
introduced in the bladder and removed 24 h post-operatively. 
Patients were discharged the day after the procedure. There were no complications after 
transurethral incision of the midline cyst and this procedure was well tolerated by all patients. 
Semen analyses was obtained 4-12 weeks post-operatively. 
RESULTS 
Table I summarizes pre- and post-operative seminal parameters of all patients. Pre-operative 
seminal parameters corresponded to the mean value of at least two semen analysis performed 
within 6 months before transurethral incision of the midline prostatic cyst. Post-operative 
seminal parameters corresponded to the mean values of at least two semen analysis performed 
at the latest follow-up. 
Effect of transurethral incision of the midline prostatic cyst on sperm volume 
Patients 3, 5, 8, 10 and II showed improvement of seminal volume after the procedure (Table 
n. No relationship was found between the positive effect of the incision and the size of the 
cyst or dilatation of the seminal vesicles. 
Effect of transurethral incision of the midline prostatic cyst on sperm quality 
Sperm concentration did not change in eight patients, decreased in patient no. 4 and increased 
only in patient no 10. (Table 1). Additionally, the percentage of motile spermatozoa and the 
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quality of motility did not change after surgery. A remarkable, but transient improvement in 
sperm quality was seen in one patient (no. 6). In the first 3 months following the transurethral 
incision of the cyst, semen analysis showed dramatic sperm improvement, but eventually the 
patient developed azoospermia again. 
Effect of transurethral incision of the midline prostatic cyst on pregnancy rate 
No spontaneous pregnancies occurred following transurethral incision. 
Table I. Semen parameters before and after transurethral deroofing of midline prostatic cyst in subfcrtile men. 
Patient no. Obstructions Semen Sperm %Motility :Motility %Abnonnal 
Signs Volume Concentration Quality 
Pre~op No 0.6 0 
- -
-
Post-op 0.9 0 - - -
Pre~op Yes 1.7 3.3 5 3 71 
Post~op 1.5 2.6 35 3 76 
Pre-op No 1.6 <0.1 - 1 ND 
Post~op 3.0 <0.1 
-
:i 1 ND 
1 
Prc-op Yes 0.6 30 
-
1 
-
' 
Post~op 0.7 1.0 1 
- -
Pre-op Yes 0.5 58 15 13 45 
I 
' Post~op 
! 
1.7 14 ! 50 13 55 
Pre-op iNo 0.8 0 !- 1 
-
, Post-op i! 0.7 25 Later 0 \ 45 Later- 4 Later 1 58 Later~ 
Prc-op i Yes 0.3 0.2 1: 1 -Post-op 0.3 0.4 1 1 
Pre~op No 0.3 115 
-
1 
-
Post-op 3.4 l1s - 1 
-
Prc~op No 0.3 0.1 - 1 
-
Post-op 0.3 0.1 
-
1 !_ 
Prc-op No 0.5 5.4 7 3 94 
Post-op 0.9 14 13 3 94 
Pre-op No 0.1 45 38 '4 84 
Post~op 1.2 46 !46 \4 90 
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DISCUSSION 
The widespread utilization ofTRUS to diagnose prostatic abnonnalities and as a diagnostic 
tool in the evaluation oflow ejaculate volume, azoospermia or oligozoospermia in subfertile 
men has resulted in more frequent detection of midline prostatic cysts (Kim et al., 1997). 
These cysts can be utricular or Mullerian duct origin (Golubuff et al., 1995). Utricular cysts 
are of endodermal origin, contain no spermatozoa and are located near the verumontanum 
whereas Mullerian cysts are of mesodennal origin, contain spermatozoa and are located more 
posterioir and nearer to the prostate base. The ejaculatory ducts enter the prostate obliquely 
posteriorly at its base, course medially and anterioly through the glandular tissue of the 
prostate and end in the prostatic urethra at the verumontanum (Globuloff et al., 1995). 
Globuloff et al. demonstrated that the ejaculatory ducts run in an almost straight course from 
the prostatic base to the verumontanum (Globuloff et al., 1995) and it is therefore believed 
that a midline prostatic cyt can be one of the causes of ejaculatory duct obstruction by lateral 
compression of the ejaculatory ducts (Fisch et al., 1992). 
Historically, ejaculatory duct obstruction was diagnosed by vasography (Pryor and Hendry, 
1991; Jarrow, 1993). A complete block in the ejaculatory ducts is conclusive for the diagnosis 
of total obstruction. The main drawback, however, is the invasiveness of the procedure, and 
the subsequent risk of iatrogenic occlusion. In contrast, TRUS is readily available, 
inexpensive and non-invasive. The ultrasonographic diagnosis ofEDO is based upon 
dilatation of seminal vesicles or abnormalities such as midline prostatic cysts or calcifications 
in the region of the ejaculatory ducts. Unfortunately, not all patients with EDO have dilated 
seminal vesicles and, conversely, not all patients with dilated seminal vesicles have EDO 
(Littup et al., 1988). Moreover, the functional implication of a midline prostatic cyst or 
prostatic calcification cannot be detennined by TRUS (Jarrow, 1996a). It provides only 
circumstantial evidence for obstruction. Nevertheless, at present TRUS has replaced 
vasography as imaging modalty for suspected ejaculatory duct obstruction. 
Several treatments forEDO caused by midline prostatic cysts, e.g. transurethral resection of 
the ejaculatory ducts (TURED). transrectal aspiration together with with sclerotherapy, 
transurethral marsupialization and open surgery of the midline prostatic cysts have been 
described (Ritchey et al., 1988; Fisch, 1992: Stricker et al., 1993; Jarrow, 1996b ). 
Currently, the standard treatment has become TURED (Fisch, 1992; Mecham et al., 1993). 
The overall success rate ofTURED has been quite good (Jarrow, l996b). In the literature 
more than l 00 ptients have been described as having had this procedure for subfertility with 
improvement in semen parameters seen in 50%. Spontaneous pregnancies occurred in 25% of 
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the cases (Jarrow, 1996b; Netto eta!., 1988). Hendry and Pryor (1992) performed a 
transurethral incision of a Mullerian cyst in 21 patients, of which 10 (48%) experienced an 
undisclosed improvement in semen quality and eight (38%) partners conceived (Hendry Wd 
Pryor, 1992). Dik eta!. (1996) described in their series of transurethral marsupialization of the 
medial prostatic cyst in patients with prostatitis-like symptoms, three patients with infertility 
of whom 2 demonstrated significant improvement of semen quantity and quality (Dik eta!., 
1996). Moreover, eight of the 10 patients with prostatitis-like symptoms who ha pre-
opertively small volume ejaculate without infertility demonstrated improvement in semen 
volume after transurthral marsupialization (Dik eta!., 1996). These results clearly advocate a 
functional relationship between midline prostatic cysts and low semen volume. Our poor 
results oftransuretlrral incision of midline prostatic cyst for infertility are therefore suprising. 
Only five (46%) patients demonstrated an improvement in seminal volume and in one patient 
improvement of sperm concentration was seen. Sperm motility was not affected in any 
patient. In our series spontaneous pregnancies did not occur after transurethral deroofing of 
the midline prostatic cyst. 
The diagnosis of subfertility caused by obstruction due to midline prostatic cyst was based on 
history, physical examination, semen analyses and TRUS. Since vasography was not used in 
the diagnostic process, a functional relationship between the midline prostatic cyst and 
obstruction was not established, which may explain our poor results. Functional investigation, 
i.e. seminal vesiculography or vasography may still be mandatory to prove the existence of an 
obstruction and to prove its removal afterwards. Secondly, the midline prostatic cyst was 
marsupial zed and the cyst walls were not resected. The edges may heal together once again 
thus allowing the obstruction to return. Theoretically, a midline prostatic cyst can cause direct 
obstruction of the ejaculatory ducts by compression, but secondary fibrosis/stenosis of the 
ejaculatory ducts might occur on different levels between the ejaculatory ducts orifice in the 
urethra and the epididymal junction. Although marsupialization of the midline cyst might 
solve the direct obstructive factor, the secondary obstruction might still be present. Digital 
massage of the seminal vesicles, possibly prior to the operation and injection with coloured 
dye, could therefore be helpful to check patency of the ejaculatory ducts following 
marsupialization of the cyst. 
Finally, an improved patient selection might influence pregnancy outcome. Patients with 
subfertility based only on low semen volume might benefit from improvement of seminal of 
seminal volume because the concomitant increase in pH of the seminal fluid may protect the 
spermatozoa against the harmful influence of the acid vaginal mucous. 
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In conclusion, our study suggests a poor efficacy of transurethral deroofing of midline 
prostatic cyst alone in sub fertile males with low semen volume, oligozoospermia or 
azoospermia. To improve the results, selective vasography o vesicography prior to an incision 
to confirm obstruction may be useful despite the potential harmful effects. Moreover, 
marsupialization of the cyst in combination with a resection of the wall of the cyst might 
improve the results. Only time will tell if these adjustments will improve the results, in terms 
of pregnancy rates, of transurethral deroofing of a midline prostatic cyst in subfertile men 
with low semen volume and/or azoo- or oligozoospemia. 
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ABSTRACT 
Microsurgical repair of obstructive male infertility is a challenge for the physician, but 
successful treatment depends on the experience and skills of the surgeon. Fertility can often 
be restored, thus avoiding the need for artificial reproductive techniques. The surgical 
procedures can be combined with sperm aspiration and cryopreservation, to be used for 
Intracytoplasmic sperm injection (ICSI) in cases of surgical failure. In this review we will 
discuss the results of microsurgical procedures for obstructive male infertility, with special 
emphasis on technical refinements and prognostic indicators. 
Recently, surgical refinements, such as the invagination technique, have been introduced for 
the vasoepididymostomy procedure, showing promising first results. This simplified 
technique enables less experienced microsurgeons to perform this difficult operation 
successfully. The procedure is indicated for men with primary infertility and epididymal 
obstruction and for vasectomised men with secondary epididymal obstruction due to leakage 
of semen from the dilated epididymal tubule with subsequent fibrosis. This can be found in 
men with a long obstructive interval between vasectomy and reversal. 
In men with obstruction of the seminal tract patency in found in 70-90% after microsurgical 
repair. In primary infertility and epididymal obstruction other anatomical abnormalities of the 
reproductive tract can be found in nearly half of them, like obstructions of the ejaculatory 
ducts. In men with extreme oligozoospermia, normal physical examination and normal 
hormonal evaluation partial obstructions of the seminal tract can be found in 50-60%. 
Vasectomy reversal is still the treatment of choice for secondary infertility after previous 
vasectomy. Although patency remains high, even after a long obstructive interval, the number 
of spontaneous pregnancies progressively decrease after a period of 10 years, due to loss of 
epididymal function and sperm motility. The main predictive factors for a successful outcome 
are the obstructive interval and the age of the female partner. Late stenosis after initial 
successful operation occurs in 12-18%: repeat reversal procedures show a patency rate of 64-
79%, pregnancies are reported in 27-31%. 
Microsurgical reconstruction of obstructive male infertility can be a very awarding procedure 
for both the infertile couple and the physician. Practical teaching courses are very helpful and 
a learning curve should be taken into account. Urologist with an interest in male infertility 
should be encouraged to learn microsurgery as a part of their surgical training. The operations 
are best performed in centres for reproductive medicine, allovving different options to be 
performed for selective cases. 
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INTRODUCTION 
Microsurgery in urology is mainly applied in obstructive male infertility and varicocele repair. 
Other indications are vascular erectile dysfunction and penile or testicular trauma. 
Obstructions of the male genital tract represent 5-10% of the causes of male infertility and in 
80% of these men surgical repair can be performed [1]. The patient presents with either 
azoospermia or extreme oligozoospermia, normal testicular volume, and normal serum 
concentrations ofFSH and Inhibin-B, both reliable markers for spermatogenesis. To finalise 
the diagnosis of a male genital tract obstruction a testicular biopsy may be required in men 
with primary infertility. 
The site of the obstruction is commonly at the epididymal level. causing dilation of the 
epididymal tubule. Back pressure in the obstructed epididymal tubule may lead to a "blow-
out" with subsequent leakage of semen in the connective tissue of the organ, resulting in 
fibrosis and scarring. Also, a long interval of obstruction will eventually cause loss of 
epididymal function, poor fertilising capacity of the spermatozoa and the formation of 
antisperm antibodies. In about 20% of the men with obstructive azoospermia fibrosis and 
other irreparable conditions of the epididymis are found during scrotal exploration and 
microsurgery cannot be performed. Furthermore, epididymal obstruction is frequently 
accompanied by congenital abnormalities of the genital tract and ejaculatory duct obstruction 
[2]. 
Epididymal obstruction can be congenital (idiopathic) or acquired, due to epididymal 
infection or previous inguinal and scrotal surgery. About 10% of the men with obstructive 
azoospermia present with a primary structural abnormality of the genital tract, like congenital 
bilateral absence of the vas deferens (CBA VD), a mild form of cystic fibrosis [3]. In these 
men part of the epididymis and the scrotal vas deferens are absent, due to an early regression 
ofthe Wolffian duct. Also, the seminal vesicles are either hypoplastic or absent, resulting in a 
low volume semen (<l.Oml) and low seminal pH (<7.0). 
Obstructions of the ejaculatory ducts are found in men with recurrent prostatitis and with 
prostatic cysts. On transrectal ultrasound the effects of distal obstructions of the genital tract can 
be found like dilations of the ejaculatory ducts and the seminal vesicles as well as calcifications 
in this region [4]. 
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In Western Europe about 10-15% of the male population rely on the vasectomy procedure as a 
contraceptive method. Since divorce rates are increasing, the demand for vasectomy reversal 
is high: in 2-6,5% of the vasectomised men a vasovasostomy is being performed [5]. 
In this review we will discuss the different aspects of microsurgical treatment of obstructive 
male infertility and focus on recent modifications, refinements of the techniques of the 
vasoepididymostomy (VES) and vasovasostomy (VVS) procedure and on the value of the 
different prognostic factors involved in refertilisation surgery for obstructive azoospermia. 
DIAGNOSTIC PROCEDURES 
Before scrotal exploration is performed in men with suspected primary obstruction a testicular 
insufficiency should be ruled out In men with small testis and high levels of FSH an impainnent 
of spermatogenesis is always present and exploration is not indicated. Ultrasound investigations 
of the scrotum can be helpful in the diagnosis of obstruction (epididymal congestion) and in 
detecting other causes of male infertility, like varicocele. Transrectal ultrasound is indicated in 
men with a history of genital infections and in case of a consistent low seminal volume (<1.0 
ml).ln 33% of the men with obstructive azoospermia abnormalities can be found on transrectal 
ultrasound investigation [6]. 
The diagnosis CBA VD can be made by careful examination of the patient. The results of the 
semen analysis always show a low seminal volume and low pH. Fructose is absent in the 
ejaculate. Genetic testing for cystic fibrosis gene mutations in both the patient and his partner 
should be performed before a microsurgical epididymal sperm aspiration (MESA) and 
intracytoplasmic sperm injection (ICSI) is performed. 
Vasography is performed during scrotal exploration and is indicated in men with a history of 
inguinal hernia repair and in primary infertility. In men with a history of gonorrhoea obstructions 
in both the vas deferens and the ejaculatory ducts may be present. For vasectomy reversal cases 
the patency of the vas deferens can simply be tested by a saline flushing through a small24-
gauge angiocatheter or by flushing with a methylene blue solution, which colours the urine 
green. 
If sperm cryopreservation is considered the patient should be screened for sexual transmittable 
diseases, like HIV and Hepatitis, for several of these viruses can be transmitted into the oocyte 
during the ICSI procedure. 
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Figure 1. End-to-side vasotubu/ostomy 
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V ASOEPIDIDYMOSTOMY 
Vasoepididymostomy (VES) is a technically demanding procedure that requires advanced 
microsurgical skills. The end-to-side vasotnbulostomy was popularised by Silber et.al. [7]. A 
higb scrotal delivery oftbe testis is performed by a longitndinal incision oftbe scrotnm, which 
can be extended in the inguinal direction in case of an unexpected inguinal obstruction. The 
tunica vaginalis is opened anteriorly and the epididymis is inspected under the operation 
microscope. Starting in the tail of the epididymis, tubular fluid is aspirated for microscopic 
examination and cryopreservation. In case of patency a vasography with saline or methylene 
blue is performed in tbe distal part oftbe vas deferens. The vas deferens is tben pulled tbrougb 
tbe tuuica vaginalis and tbe serosa of tbe vas is fixated to tbe tuuica vaginalis of tbe epididymis. 
A dilated part oftbe epididymal tnbule is opened anteriorly under tbe microscope and a 10-zero 
nylon sutnre is used for tbe anastomsis between tbe opened tnbule and tbe lumen of tbe vas 
deferens (Fig.!). Finally, the serosa oftbe vas deferens is fixated to tbe tuuica vaginalis oftbe 
epididymis. 
The reported patency rates after the procedure range from 64-78%, spontaneous pregnancies 
occur in 31-56% [7,8,9]. Passage tbrougb a substantial portion oftbe epididymis is essential for 
the fertilising capacity of the spermatozoa. An anastomosis between the vas deferens and the 
head oftbe epididymis usually does not result in spontaneous pregnancy. NF!!CSI procedures 
are indicated for these couples. Recently, Berardinucci et. al. reported that anatomical 
abnormalities are often found in men witb suspected epididymal obstruction [2]. In a series of 
147 men evaluation oftbe reproductive tract resulted in 52.7% epididymal obstructions and 
47.3% otber anatomical abnormalities, like vasal obstruction and aplasia, epididymal atresia and 
intra-testicular obstructions. The outcome of microsurgical repair in men with other anatomical 
obstructions was poor and in 35% post-testicular obstructions were encountered that precluded 
successful VES. In men with an infectious etiology spermatozoa were found in the ejaculate 
postoperatively in 76%, in idiopathic cases this was ouly 32%. Late failure after initial patency 
was reported as higb as 25%, and therefore tbe procedure should be combined witb epididymal 
sperm aspiration and cryopreservation. Recently, Berger et.al. Introduced an invagination 
technique modification to facilitate tbe anastomosis between tbe epididymal tnbule and tbe 
lumen of tbe vas deferens, witb high initial patency results [1 0]. The dilated epididymal tnbule is 
exposed through a small incision in the tunica vaginalis and slight pressure of the epididymis by 
tbe tbumb and tbe index finger is applied. 
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Figure 2. Vasoepididymostomy by a tubular invagination technique, ·using 2 double-armed 10-
zero nylon sutures. (From: Marmer et al., JUral 2000, 163:483-486) 
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Three double-armed I 0-zero nylon sutures are placed through the anterior wall of the tubule 
before opening the lumen and fixated insight-out to the mucosa of the vasal lumen in a triangular 
fashion. A tubulotomy is performed in the middle of the three sutures and the seminal fluid is 
examined for spermatozoa. The anastomosis is created by this invagination method at six sites 
for mucosal adaptation, using only 3 double-armed sutures. The procedure has recently been 
modified by Marmer et.al., using only 2 double-armed 10-zero sutures (Fig.2) [II]. Others have 
also shown the advantages of :invagination techniques in an animal model [12]: it is easier to 
learn than the end-to-side procedure and shows equally effective. In small series the patency was 
as high as 90% and already established 3 months after the operation. 
V ASOV ASOSTOMY 
Microsurgical repair after vasectomy can be a very successful procedure, since both patency and 
pregnancy results are high under good surgical conditions. The advantage of microsurgery is that 
it enables the surgeon to perform a delicate and exact alignment between the proximal and distal 
part of the dissected vas deferens. 
A high scrotal delivery of the testis is perfonned, allowing the surgeon to perform an 
anastomosis even in the lower inguinal region in case the site of the vasectomy is located here. A 
vertical incision is preferred because it can be extended into the inguinal region, if necessary. 
The site of the previous vasectomy is identified and both ends of the vas deferens are mobilised 
for a tension free anastomosis. Stripping of the vas should be avoided since this will cause 
circulatory problems and subsequent stenosis of the vas deferens. The patency of the distal 
(inguinal) part of the vas deferens is tested by flushing a small amount of saline through a 24-
gauge angiocatheter into the lumen. In case of resistance a methylene blue solution can be used. 
Under the microscope all fibrotic tissue, which can be recognised by white scarring bands in the 
seromuscular layer of the vas deferens, should be excised with a microlm.ife. 
The proximal part of the vas deferens is cut in a shuilar way and any fluid from the testicular part 
of the vas deferens is examined for the presence of spermatozoa. Motile sperm can usually be 
found in clear or white seminal fluid, creamy thick 'iooth-paste" I ike fluid usually does not 
contain spermatozoa and is often seen in cases of epididymal blockage [13]. The absence of fluid 
or spermatozoa is an indication for epididymal inspection: if the epididymis is dilated entirely, 
the dissection of the vas deferens should be continued until good semen quality is found in a 
more proximal part. A VVS procedure in men with absent spermatozoa in the vasal fluid will 
lead to a patency of 50-60%, provided that there is no epididymal blockage or fibrosis. In case of 
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an epididymal obstruction a VES procedure is indicated. Patency can be expected in 71-86% 
and the pregnancy rate after 2 year was found to be 44-65% [13,14]. 
In case of a large defect between both ends of the vas deferens length can be gained by 
mobilising the tortuous proximal part of the vas deferens. The dissection should be between the 
tail of the epididymis and the testicular end of the vas deferens, leaving adequate tissue 
surrounding the vasal end for adequate nutritional supply. Unrolling of the tortuous part of the 
proximal vas deferens should be avoided, since this will cause vascular impairment and 
subsequent stenosis. More length can be gained by mobilising the tail of the epididymis from the 
testis. Small vessels between the testis and the epididymis should be cauterised using bipolar 
diathermia only. 
The anastomosis can be performed by a two-layer technique [14] (fig.3) or a modified one-layer 
technique [15] (Fig.4). Although many authors prefer the two-layer technique, both procedures 
show similar results in tenus of patency and pregnancy. The advantage of the modified one-layer 
procedure is that it requires less surgical skills and can be performed bilaterally within 2 hours. 
Identification of the lumen can be facilitated by using methylene blue or a marker pen for 
colouring the vasal mucosa on both sides. For the anastomosis double-armed monofilament non-
absorbable 9-zero or 10-zero sutures are used, allowing the needles to be placed inside out on 
both sides of the vas deferens. Six stitches are used for the mucosal anastomosis (inner layer) 
using a 10-zero double-armed suture with a small round needle and another six stitches for the 
seromuscular layer, for which a 9~zero suture with a cutting needle can be applied. 
The operative success of the vasectomy reversal procedure depends on several factors: 
-Gentile tissue handling, taking good care of the nutritional vessels of the vas deferens. 
-Accurate mucosa to mucosa approximation 
-Tension free leak-proof anastomosis. 
- Excision of fibrotic vasal tissue. 
-The presence of spermatozoa in the proximal (testicular) vas deferens 
-A modified on-layer or a two-layer microsurgical anastomosis of the vas deferens. 
-Bipolar diathermia and non-absorbable 9-zero and 10-zero double armed sutures. 
Late stenosis of the anastomosis occur in about 12-18% of the patients 'Within one year. Failure 
after a first VVS is usually caused by stricture of the anastomosis and epididymal blockage. Only 
in a few men an epididymal dysfunction or a testicular insufficiency is the cause of the failure. 
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Figur 3. Two layer vasovasostomy 
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Figure 4. Modified one-layer vasovasostomy 
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PROGNOSTIC FACTORS 
Silber et.al. was the first to describe an inverse relationship between the duration of the 
obstructive interval and the patency and pregnancy rates. The pregnancy rate after vasectomy 
progressively decreases with the duration of the obstructive interval [16]. Although, even in men 
with an interval> 15 years patency rate can be as high as 60-70%, pregnancy rate is only 20-
30%, mainly due to loss of epididymal function. In a personal series of223 vasovasostomy 
procedures, 118 men had an interval of more than 10 years. Table 1 shows the results of the 
patency and pregnancy rates at different interval periods between vasectomy and VVS. In 
selective cases when no spermatozoa can be fotu1d in the fluid of the proximal vas deferens, a 
YES should be performed at a site where motile spermatozoa are identified in the epididymal 
fluid. 
The age of the female partner is a strong predictive factor in the treatment of infertile couples 
[ 17]. The decline of ovarian function in aging woman results in a decrease in pregnancy rate, 
both spontaneous and with artificial reproductive techniques. From the results of ART in older 
woman it is estimated that the fertility potential of a woman aged 35 is only 50% of the fertility 
of a woman aged 25 years; by the age of 38 years this is further reduced to only 25%, and over 
the age of 40 years it is less than 5%. Silber et al. reported a dramatic decrease in delivery rates 
per ICSI cycle in women older than 36 years: the rate dropped from 34% in woman aged 30-36 
to 13% for women aged 37-39 and only to 4% in woman 40 years and older [18]. 
It has been suggested that men with older female partners who seek treatment for post-
vasectomy infertility should undergo sperm aspiration and rcsr rather than vasectomy reversal. 
Recently, Deck et. al. compared the results of vasectomy reversal in men with ovulating female 
partners older than 37 years to the results of sperm retrieval and ICSI for woman in the same age 
category [19]. The ongoing pregnancy rate was 22% after vasectomy reversal and 8% per cycle 
in the ICSI group. They concluded that vasectomy reversal is the treatment of choice, although 
pregnancy rates were low for both groups. Sperm retrieval and ICSJ did not improve the final 
outcome of these couples. 
Table 2 shows the results of semen analysis after 224 VVS procedures: in men with a long 
obstructive interval a decrease in both the sperm count and the progressive motility is seen. The 
low number of motile spermatozoa can be the consequence of epididymal insufficiency, reactive 
oxygen species (ROS) and antisperm antibodies [20,21,22]. The role of the epididymis is storage 
and maturation of spermatozoa, and passage through the organ is essential for normal 
fertilisation. Epididymal insufficiency is seen after a long obstructive interval with dilatation of 
the epididymal tubule, subsequent leakage of seminal fluid in the interstitium of the organ and 
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fibrosis. ROS are generated by leukocytes and spermatozoa are highly susceptible to oxidation, 
since enzymes for neutralisation ofROS are absent in germ cells. Leukocytospermia can be the 
consequence of the epididymal obstruction and a low-grade infection of the genital tract [20]. 
Antisperm antibodies are found in 20-50% of the ejaculates after the operation, but most of these 
men prove to be fertile [21,22]. Antisperm antibodies may cause sperm agglutination and low 
motility. IgA antibodies on the cell surface of the spermatozoa are bound to anti-IgA in the 
cervical mucus, preventing further progression of the spermatozoa into the uterine cavity. Sperm 
washings and intra-uterine insemination is indicated in couples with major IgG and IgA binding 
and low motility. Severe oligozoospermia with low sperm count and motility is usually the 
consequence of a stricture at the anastomsis due to imprecise microsurgical alignment of the 
vasal lumen, malnutrition of the vas deferens or leakage of seminal fluid causing granuloma and 
fibrosis [14]. These men should be treated by a repeat reversal procedure rather than ART, since 
both patency and pregnancy rates are acceptably higb after a second procedure. 
The repeat reversal procedure is indicated for men 'With initial patency and late stenosis of the 
anastomosis resulting in severe oligozoospermia or azoospermia. Partial obstruction with 
oligozoospermia and azoospermia after an initial good semen analysis results occurs in 12-18%. 
A second reversal procedure will result in patency rate of 50-80% and spontaneous pregnancies 
were reported in 20-50% [23,24]. Therefore, a repeat reversal with intraoperative sperm 
aspiration and cryopreservation appears to be the first treatment option in these couples. 
ART OR SURGERY? 
Sperm retrieval and ICSI has been advocated as the treatment of choice for male infertility, 
regardless the etiology. However, the results of microsurgical treatment of obstructive male 
infertility as compared to NF/ICSI results are much in favour for surgical treatment [25,26]. 
Pregnancy rates of 44-65% after vasectomy reversal are better than the ongoing pregnancy rate 
after MESAIICSI of29%. Also, the less successful VES procedure still results in a spontaneous 
pregnancy rate of3l-56% [25]. Furthermore, the cost per delivery after microsurgery and after 
MESA!ICSI is much in favour of surgical treatment [26]. With surgical treatment several 
complications and disadvantages of in vitro reproductive teclmiques can be avoided, like 
hormonal treatment of the partner, transvaginal ovum pick-up and embryo transfer and the 
higher risk for offspring with a (sex-) chromosomal abnormality after ICSI procedures. 
Therefore, microsurgical epididymal sperm aspiration and intracytoplasmic sperm injection 
should be reserved for couples not amenable to microsurgical reconstruction of obstructive 
azoospermia. 
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SUMMARY 
Microsurgical repair of obstructive male infertility is a challenge for the physician, but 
training and experience are mandatory for good results. Fertility can often be restored or 
improved, thus avoiding the need for artificial reproductive techniques. The procedures can be 
combined with sperm aspiration and cryopreservation, to be used for ICSI in cases of failed 
microsurgery. Comparing microsurgery to MESAIICSI, both the results and the costs are 
much in favour of surgery. Urologist with an interest in Andrology should be encouraged to 
learn microsurgery as a part of their surgical training. The operations are best performed in 
centres for reproductive medicine, allowing different options to be performed for selective 
cases. 
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TABLE 2: results of the sperm count, sperm progressive motility and antisperm antibody 
(MAR) test according to the lenght of the obstructive interval between vasectomy and 
reversal. 
SPERM COUNT < l.OMILJ.IML 1.0-20 MILJ.IML > 20 MILJ.IML < !0% MOTII.TIY MAR-1EST POS. 
("lo) (%) ("lo) (%) ("lo) 
OBS1RUCTIVE 8/62 (12.9) 34/62 (54.8) 20/62 (32.3) 9/30 (30.0) 29/41 (70.7) 
IN1ERVAL 
<!OYEARS 
OBS1RUCTIVE 14/77 (18.2) 42/77 (54.5) 21/77 (27.3) 25/46 (54.3) 18/31 (58.1) 
IN1ERVAL 
> !OYEARS 
Student's T -test 
(P-value) N.S. N.S. N.S. P=0.025 N.S. (P=0.49) 
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Table l. Patency and pregnancy rates after vasovasostomy at different intervals (Years) 
between vasectomy and reversal. 
PERCENTAGE. 
1-SY 
!!!l Patency 
•Pregnancy 
6-10 y 11-15 y >15Y 
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Abstract 
Male genital tract obstructions may result from infections, previous inguinal and scrotal 
surgery (vasectomy) and congenital bilateral absence of the vas deferens (CBA VD). Micro-
surgery can sometimes be successful in treating the obstruction. In other cases and in cases of 
failed surgical intervention, the patient can be treated by microsurgical or percutaneous epidi-
dymal sperm aspiration (MESA, PESA) or testicular sperm extraction (TESE) and intra-
cytoplasmic sperm injection (ICSI). We present the results of 39 ICSI procedures for 
obstructive azoospermia in 24 couples. The aetiology of the obstruction was failed 
microsurgery in 11 patients, CBA VD in nine and genital infections in four. Sperm retrieval 
was accomplished via MESA in four cases, PESA in 18 cases and via TESE in 11 cases. 
TESE was only applied when PESA failed to produce enough sperm for simultaneous ICSI. 
In six patients the ICSI procedure was performed with cryopreserved sperm after an initial 
PESA procedure. Fertilization occurred in 47% of the metaphase II oocytes; embryo transfer 
was petformed in 92% and resulted in a clinical pregnancy in 13/39 procedures. Ongoing 
pregnancy was found in 10/39 procedures. One pregnancy was terminated early after prenatal 
investigation showed a cytogenetic abnormality (47,XX+l8, Edwards syndrome). The other 
nine pregnancies resulted in a life birth of 10 children, without any congenital abnormalities. 
Epididymal and testicular retrieved spermatozoa were successfully used for ICSI to treat 
obstructive azoospermia, and resulted in an ongoing pregnancy in 10 of24 couples ( 41 ,6%) 
after 39 ICSI procedures, a success rate of25.6% per treatment cycle and of27,7% per 
embryo transfer. 
KEY WORDS: ICSI -MESA- PESA- TESE -OBSTRUCTIVE AZOOSPERlVIIA 
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Introduction 
Azoospermia is found in 10% of male infertility cases and is caused by a testicular 
insufficiency in the majority of patients. In 20% a bilateral obstruction of the male genital 
tract is responsible for the azoospermia (Hendry et al., 1994), In the presence of a history of 
previous scrotal or inguinal surgery or recurrent genital infection an obstruction can be 
suspected. These patients are characterised by normal testis volume and normal levels of 
gonadotrophins [Luteinizing hormone(LH)/follicular stimulating hormone(FSH)], In 1-2% of 
the infertile male population congenital bilateral absence of the vas deferens (CBA VD) is 
found (Anguiano and Oates, 1992), The definite diagnosis of obstructive azoospermia is made 
by performing a testicular biopsy, showing normal spermatogenesis. 
Microsurgical repair of vas deferens obstructions or epididymal blockage can result in 
spontaneous pregnancies in 27%- 56% of cases (Belker et al., 1991; Jarow et al., 1997), The 
results are determined by several factors, including the site and the duration of the 
obstruction, epididymal function, recurrent genital tract infections and sperm antibodies. In 
cases of poor sperm quality after the operation assisted reproductive techniques (ART) have 
been applied successfully, Recently, intracytoplasntic sperm injection (ICSI) has become 
available for treatment of severe oligospermia (Palermo eta/., 1992). This technique has also 
been applied to treat azoospermia if viable sperms could be retrieved from the epididymis or 
the testis, giving results similar to those of ICSI for oligospermia (Silber et aL, 1994; Devroey 
eta/,, 1994 ), 
We present the results of 39 ICSI procedures for obstructive azoospermia in combination with 
nticrosurgical epididymal sperm aspiration (MESA), percutaneous epididymal sperm 
aspiration (PESA) or testicular sperm extraction (TESE). 
Materials and Methods 
Patients. The combination of ICSI and sperm retrieval was offered to couples with male 
factor infertility due to bilateral genital obstruction. The mean age of the treated males was 
38.1 years (SD 634), the mean age of the treated females was 34,1 years (SD 4,2). All males 
had normal testicular volume, normal serum FSH concentrations and~ on testicular biopsy, a 
normal sperm count according to the Johnsen scoring system (Johnsen, 1970). Azoospermia 
was found on at least two occasions. In men with CBA VD genetic analysis of common cystic 
fibrosis transmembrane conductance regulator (CFTR) gene mutations was performed of the 
patient and his spouse. These couples were counselled for genetic risks concerning cystic 
fibrosis inheritance before the procedure. In cases of pregnancy all patients were offered 
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prenatal screening, amniocentesis and ultrasound examination. Informed consent was 
obtained in all couples after explanation of the experimental nature of the treatment with 
known and unknown medical and genetic risks. 
Ovulation induction and oocyte retrieval. Pituitary do\VIl-regulation was achieved using a 
gonadotrophin releasing hormone analogue (GnRHa) Triptoreline (DecapeptylR, Ferring, 
Hoofddorp, The Netherlands) subcutaneously once a day. Multiple follicle development was 
induced with Human Menopausal Gonadotrophins (HumegonR, Organon, Oss, The 
Netherlands). Depending on the size of the follicles and the serum oestradiol concentrations a 
single injection of 10,000 ru of Human Chorionic Gonadotrophin (HCG)(PregnylR, Organon) 
was administered and a transvaginal ultrasound-guided follicular aspiration was performed 
34-36 h later. 
Oocyte processing. Oocyte preparation was performed according to the protocol as described 
by Palermo (Palermo eta/., 1992) with a modification to a maximum of3 min. hyaluronidase 
treatment. Only intact oocytes sho'Ning a polar body were microinjected. 
Sperm retrieval. The .MESA procedure was performed under general anaesthesia as an 
outpatient procedure. After exposure a dilated tubule of the epididymis was microsurgically 
opened and its flnid examined for the presence of motile spermatozoa. After four MESA 
procedures had been performed, the procedure was abandoned in favour ofPESA in all 
subsequent cases. Percutaneous aspiration of the epididymal head (Tsirigotis el a/., 1995) was 
performed under local anaesthesia of the spermatic cord (figure 1). In the case of an unsuc-
cessful PESA procedure a testicular excisional biopsy (TESE) was performed for extraction 
of viable spermatozoa (Silber eta/., 1995). 
Sperm processing. Following MESAIPESA, the epididymal aspirates were diluted in 10 ml 
in iivitro fertilization (NF) medium and centrifugated for 10 min at 1500g. The supernatant 
was removed and the pellet was resuspended again in l 0 ml IVF medium and the same 
centrifugation procedure was performed. After removal of the supernatant the cell-pellet was 
incubated until the start of the ICSI procedure. Approximately 1 1 ofthis suspension was 
added to 50 1 of polyvinylpyrrolidone (PVP) solution or diluted in 50 1 NF medium in case 
of very poor motility. 
During the TESE procedure, the testicular biopsies were performed under local or general 
anaesthesia. After obtaining a testicular sample, its adequacy of the sample was immediately 
assessed: depending on the outcome of the first sample (i.e. the presence or absence of 
spermatozoa) more testicular tissue might be necessary. In the laboratory the tissue sample 
was shredded by means of two sterile glass slides and a suspension of the cells was made in 
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IVF medium. During an incubation period of at least 2 h, spermatozoa were allowed to gain 
motility. After the incubation period the suspension was centrifuged for 5 min at 300g and the 
supernatant was removed and recentrifuged for 10 min at 1500g. Shortly before the injection 
procedure- I I of the cell pellet suspension was added to 50 1 of!VF medium. 
During the MESAIPESA and TESE laboratory procedures none of the suspensions or 
washings media was discarded. If spermatozoa were absent in the pellet, they might still be 
found in one of the other suspensions. 
ICSI procedure. Commercially available injection pipettes (GyootecR, Malden, The 
Netherlands) were used with a outer and inner diameter of7 m and 5 m respectively. The 
oocyte holding pipette had an outer and inner diameter of90 m and I 0 m respectively. One 
drop of sperm-PVP solution was placed in the centre of a Petri dish, surrounded by 5 drops of 
NF medium containing metaphase II oocytes. 
All drops were covered by paraffin oil. The ICSI procedure was performed under a 400 x 
magnification, using hydraulic micromanipulators and microinjectors. A single spermatozoon 
was isolated, inunobilized and aspirated tail-first into the injection pipette. The oocyte was 
fixed by the holding pipette and the injection pipette was pushed through the zona at the 
opposite side. Breakage of the ooplasmic membrane was initiated by gentle suction with the 
injection pipette, and one spermatozoon was injected immediately after membrane breakage 
was observed. 
Fertilization. 16-18 h after microinjection, the oocytes were microscopically examined. 
Normal fertilization was reached by the presence of two pronuclei and a second polar body. 
Depending on the day of embryo transfer, embryo cleavage was judged 3, 4 and 5 days after 
the ICSI procedure. A maximum of2 embryos was transferred into the uterine cavity and 
supernumerary embryos of good morphological quality were cryopreserved. Pregnancy was 
confirmed 18 days after oocyte retrieval by a positive pregoancy test. A clinical pregoancy 
was defmed as the presence of at least one gestational sac with a fetal heart beat. An ongoing 
pregnancy was defmed as a clinical pregnancy beyond 12 weeks of gestation. 
Results 
The combined sperm retrieval-ICSl procedure included 39 treatment cycles in 24 couples. 
Azoospermia was present in all men in at least two semen samples. CBA VD was present in 
nine patients, a history of recurrent infections in four and a previous surgical intervention of 
the scrotum or the inguinal region, including failed microsurgery, in 11. 
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Figure I. Percutaneous epididymal sperm aspiration (PESA). A 19 gauge butterfly needle is 
inserted into the epididymal head. A mild vacuum is applied and the butterfly needle is moved 
gently within the epididymal head Clear epididymal fluid is aspirated into the collecting tube 
for microscopical examination. 
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MESA was performed in the first 4 patients only, and was successful in all. Subsequently, 
PESA was introduced as the first approach for epididymal sperm retrieval for future cases. 
PESA showed successful in 18/29 (62%) procedures. In 11 cases offailed epididymal sperm 
retrieval an excisional testicular biopsy was performed under local or general anaesthesia in 
the same procedure, showing viable sperm in 9/11 (82%) biopsies. 1n one patient a repeated 
biopsy had to be performed on the same day, which yielded viable spermatozoa, which were 
successfully used for ICSI. Only in one case ofTESE no viable sperm could be found after 
incubation. Sperm cryopreservation was performed only after epididymal retrieval and was 
successfully used in 6 patients as a sperm source where the first combined cycle had failed. 
Table I sununarizes the results ofthe 39 treatment cycles. Oocyte retrieval resulted in a total 
number of 454 oocytes, of which 67.7% had extruded the frrst polar body (metaphase II oocy-
tes). Fertilization was found in 47% of the metaphase II oocytes after the ICSI procedure. The 
fertilization rate and embryo transfer after MESA/PESA and TESE was similar. Transfer of 2 
embryos into the uterine cavity was performed in 36/39 (92%) cases, resulting in a clinical 
pregnancy in 13/39 (33,3%). 1n 8 cycles, 26 supernumerous embryos of good morphological 
quality were cryopreserved. Thawing of the embryos was performed in 5 patients and 
transferred in 2 couples. This, however, did not result in clinical pregnancies. J\.1ESAJPESA 
produced 27% ongoing pregnancies, TESE resulted in 36% ongoing pregnancies. Finally, 10 
ongoing pregnancies occurred in 24 couples (41,1 %), a pregnancy rate of25,6% per treatment 
cycle and 27,7% per embryo transfer. Frozen-thawed epididymal spermatozoa were succes-
sfully used for a second ICSI procedure in 6 couples. Unfortunatelly, no pregnancy occurred 
in these patients. Amniocentesis was performed in eight out of 10 pregnancies, and gave 
normal karyograms in seven pregnancies. One pregnancy was terminated early for trisomy 18 
(47XX+ !8, Edwards syndrome). Nine deliveries occurred at term, resulting in 10 babies with 
no obvious congenital malformations. Birth weight was low in two chlldren ( <p50; 
Kloosterman, 1970), one singleton and one twin baby (Table 2). 
Discussion 
Ductal obstruction occurs in 20% of azoospermic patients. Acquired ductal obstructions 
account for most of the cases of obstructive azoospermia and can sometimes successfully be 
treated by microsurgery. Infections of the ductal system and surgery of the scrotum and the 
groin are the main causes of this type of obstructions. 
Surgical sperm retrieval has been introduced as an alternative for microsurgery and for 
treatment of failed vasectomy reversal. Initial attempts of!VF with epididymal sperm showed 
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limited results, due to poor sperm quality after retrieval (Temple-Smith et al., 1985; Ptyor et 
al.. 1984). In 1988 Silber introduced a microsurgical technique of sperm aspiration, the 
MESA procedure, which showed successful in 10 of32 cases ofCBA VD (Silber et al., 1988). 
The combined MESA/IVF procedure showed a pregnancy rate of 10 - 14% (The sperm 
microaspiration retrieval techniques study group., 1994). Recently, the ICSI procedure has 
been introduced for the treatment of severe male factor infertility (Palermo et al.. 1992). 
Combining the ICSI procedure with the MESA procedure has resulted in high fertilization 
rate and pregnancies in 31 - 34% per treatment cycle (Devroey et al., 1994; T ournaye et al .. 
1994). 
We have performed the ICSI procedure with surgically or percutaneously retrieved sperm 
from the epididymis (MESA/PESA) or the testis (TESE) in 39 treatment cycles. PESA was 
successful in 62% of cases and was introduced as a minimal invasive technique of sperm 
retrieval in an outpatient clinic setting under local anaesthesia (figure 1). PESA has been 
proved successful in several reports in the majority of cases of obstructive azoospermia 
(Tsirigotis et al .• 1995; Collins et al., 1996; Craft et al., 1995). The advantages ofPESA are: 
minimal discomfort for the patient, low complication rate compared to open surgery, 
repeatable procedure showing clear aspirated fluid with usually minimal blood contamination 
and less debris. PESA does not require microsurgical skills, is easy to learn and can be 
petformed as an outpatient clinic procedure. In a recent report PESA was shown to be as 
' 
effective as MESA with comparable pregnancy rates (Meniru et al., 1997). 
In a series of 47 men PESA was unsuccessful in 11 cases and a subsequent rvrESA procedure 
was performed, showing viable sperm in only 2 cases (Tsirigotis eta!., 1995). In cases of non-
obstructive azoospermia MESA and PESA were usually unsuccessful and a testicular biopsy 
was performed. 
Testicular biopsy could be an alternative for PESA as a source of sperm. Successful 
harvesting of spermatozoa has been reported with TESE using both the open biopsy technique 
and more recently the testicular fine needle aspiration (TEFNA), although needle biopsies 
showed less effective as compared to open biopsies (Friedler et al., 1997). Late complications 
have been described after testicular sperm retrieval techniques, including inflammation, 
haematoma and even devascularization of the testis (Schlegel eta!., 1997). Therefore we 
believe that PESA should be performed first in cases of obstructive azoospermia. 
We have chosen to treat only obstructive cases of azoospermia because ofunknovm medical 
and genetic risks of treating azoospermia due to testicular insufficiency. It has been shovm 
that non-obstructive azoospermia can be associated with cytogenetic abnormalities, such as a 
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high number of sex chromosome aneuploidy in these men (Yoshida eta!., 1995; Persson et 
a/., 1996) and (micro)deletions of theY chromosome (Reijo eta/., 1995). 
In this study nine cases of CBA VD were selected for this treatment. CBA VD is found in 2% 
of the infertile men and has recently been described as a primary genital form of cystic 
fibrosis. CBA VD is highly associated with mutations of the cystic fibrosis transmembrane 
conductance regulator gene (CFTR, Oates and Amos, 1994). Since CBAVD is accompanied 
by the absence of the seminal vesicles these men consistently produce a low volume and a 
low pH semen. Spermatogenesis in CBA VD appears nonnal, but sperms derived from the 
caput epididymis show to have a low fertilizing capacity, because of their short passage 
through the epididymis (Silber eta/., 1988). In couples with CBA VD-related infertility gene-
tic screening of the patient and his partner is mandatory before MESNICSI procedures are 
performed. The risk of inheritance of CF or CBA VD is mainly determined by the presence of 
a CFTR-gene mutation in the partner (1:25): if she also carries a mutation there is a 25-50% 
chance of a form ofCF (severe, mild, CBA VD) in the offspring (Angniano and Oates.l992). 
In all treated cases no common mutations of the CFTR gene were found in the female 
partners. 
In conclusion, ICSI has been shown to give high number of fertilization rates with ejaculated, 
epididymal and testicular spermatozoa. We have combined ICSI with surgical and 
percutaneous sperm retrieval in men with bilateral obstruction of the genital tract, resulting in 
an ongoing pregnancy rate of 25,6% per treatment cycle. Non-obstructed cases of azoosper-
mia were excluded from this treatment for potential genetic risks. 
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Table 1: Results of391CSI cycle with epididymal (MESAIPESA), testicular (TESE) 
retrieved spermatozoa and cryopreserved (CRYO) spermatozoa after initial PESA procedure. 
Oocytcs Embryo Pregnancy Ongoing I Number 
of Cycles 
MTI oocytes ! Fertilization 
! (%) transfer(%) (%) pregnancy(%) 
' 
' 
MESA!PESA 22 275 186 1011186 21/22 (95) 9/22 (41) 6/22 (27) 
(54) 
TESE 11 127 90 
' 
32/90 9111 (82) 4/11 (36) '4/11 (36) 
(36) ! I 
' CRYO 6 52 27 9/27 6/6 (!00) i 0/6 (0) 
(after PESA) (33) 
Total 39 454 303 1421303 36/39 (92) 13/39 (33) 10/39 (25.6) 
(47) 
Table 2: Pregnancy and delivery results of39 ICSI~proccdurcs combined with surgical or percutaneous 
spermatozoa retrieval. 
Patient Prenatal cytogenetics Delivery WF Birth weight (g) Percentile (P) 
number terms * 
1 46.XX 38 weeks F 3555 P90 
2 46.XY 41 weeks ;;! 4110 P95 
3 46.XY 37 weeks M 2435 P15 
4 46,XY 36 weeks M 2660 PSO 
5 46,)()( 35 weeks F 2270 P40 
(twin) 46,)()( 35 weeks F 2370 PSO 
6 47.XX + 18 (trisomy 18) Early F 
termination 
7 46.XX 42 weeks F 4160 P95 
8 ,_ 41 weeks F 3990 P90 
9 - 41 weeks ,F 4190 P90 
10 46,XY 41 weeks M 3760 P75 
* Kloosterman et a!.. 1970. 
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•·counseling in reproductive medicine start by obtaining an accurate diagnosis. The medical 
history, physical examination and various laboratory tests of both partners are generally 
required" (Rowe et al., 1993). 
Aim of the thesis 
The aim of this thesis was to optimize the diagnoses of obstructive male infertility and to 
evaluate treatment options and risk factors in these couples. Therefore, several studies were 
performed in men with either severe oligozoospermia or azoospermia vvith suspected 
obstruction of the male reproductive tract. Diagnostic studies focused on the true incidence of 
obstructions of the seminal path, the genetic background of severe male factor infertility and 
the associated abnormalities found in these men. Furthermore, the current treatment options of 
obstructions of the male reproductive tract were critically analyzed. 
The introduction 
A review is presented on the different factors associated with male infertility and the possible 
causes of unexplained male infertility are discussed. The etiology of male infertility is 
partially knovm and more research on the pathogenesis and treatment of unexplained male 
infertility is needed. 
Male infertility is most often caused by testicular and epididymal failure and for this non-
obstructive male infertility a new concept of testicular dysgenesis was introduced recently: a 
disruption of embryonal programming and gonadal development during fetal life can result in 
both reduced fertility, an increased risk of cryptorchidism, hypospadias and testicular 
malignancy in adulthood. Evidence for this concept comes from epidemiological observations 
(Skakkebaek eta!., 2001). An increasing incidence of testicular dysgenesis, including 
testicular cancer, may reflect adverse effects of environmental factors, in particular those 
capable of disrupting hormonal balance in the developing testis. Future epidemiological 
studies in male reproductive health should focus on the different aspects of environmental and 
genetic influence on gonadal function and development (Rajpert-De Meyts et a/.,2001). 
Despite marked progress that has been made in elucidating the genetic basis of male 
infertility, our current knowledge of the genes involved in gametogenesis and meiosis is still 
incomplete. Many genes are involved in the complex process of spermatogenesis, both 
autosomal and sex-chromosomal genes, and we are beginning to understand their functions 
from animal models (Cooke eta/., 1998). 
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Gene defects, which might normally be lost or eliminated by natural means can be transmitted 
with ICSI to the offspring, since this technique bypasses the normal physiological 
mechanisms related to fertilization (Chandley et aL, 1998). Also, in men with severe male 
factor infertility the number of aneuploid spermatozoa was found increased, particularly for 
the sex chromosomes (Martinet aL, 1996). Infertile men, even with a normal karyotype, 
showed to have decreased chromosomal recombination and pairing during meiosis, resulting 
in meiotic arrest and non-disjunction of the sex chromosomes (Speeder aL,1990). Genetic 
studies, including karyotyping and counseling are essential in the work-up of these couples: if 
pregnancy is achieved, especially by ICSI, prenatal cytogenetic and DNA testing can be 
offered. 
Azoospermia was reviewed, including epidemiology, classification, etiology, genetic factors 
and treatment. Obstructive and non-obstructive azoospermia as well as the congenital and 
acquired causes of obstructions of the seminal path were detailed. An algorithm of the 
diagnostic work-up of azoospermia and severe oligozoospermia is provided, used as the basis 
for the studies presented in this thesis. 
Obstructions of the reproductive tract 
Obstructions in azoospermic men are defined as men presenting with normally sized testes, 
normal hormonal evaluation and a testicular biopsy revealing normal spermatogenesis. 
Subtotal obstruction of the reproductive tract is less well defined and, therefore, we 
prospectively investigated all men presenting with severe oligozoospermia for possible partial 
obstruction of the seminal path. Subtotal obstruction was found highly prevalent in men with 
severe oligozoospermia, normal size testes and normal FSH. Microsurgical repair next to 
epididymal sperm aspiration and ICSI may be considered in these couples. This concept needs 
further evaluation, confmning these first results in 78 men and comparing the results of 
microsurgery to ICSI, with and without surgical sperm retrieval, in men with severe 
oligozoospermia. 
The cystic fibrosis gene and obstructive male infertility 
Congenital bilateral absence of the vas deferens became defined as a genital form of cystic 
fibrosis, since 85% of these men are found to have at least 1 CFTR gene mutation, but most of 
them are without obvious non-genital symptoms of CF (Anguiano eta/., 1992). We analyzed 
21 men with CBA VD for symptoms of CF by performing an extensive medical history taking, 
physical examination, pulmonary function tests, sweat tests and rectal suction biopsies for 
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measuring interstitial chloride excretion. At least half of these men also have non-genital 
symptoms ofCF. The group was quite heterogeneous in the different abnormalities found and 
no straightforward relationship between phenotype and genotype for CFTR was found. CFTR 
gene mutations are related to obstructive azoospermia with low seminal volume and pH (Mak 
eta/, 2000). Some patients in our study had only partial absence of the vas deferens in the 
abdominal region. A wide spectrum of phenotypical variability of anomalies in the 
reproductive tract associated with both CF and CBA VD was recently described (Jarvi eta/., 
1998). Although virtually all CF males have CBA VD and are azoospermic, a scrotal vas 
deferens is present in 20% of men with CF. Furthermore, CFTR gene mutations were found in 
4 7% of men with idiopathic epididymal obstruction. Thus, it seems that a broad spectrum of 
Wolffian duct abnormalities may be associated v.rith CFTR gene mutations, even in men with 
ejaculatory duct obstruction (Meschede eta/., 1998). Therefore, it seems prudent to screen all 
men with unexplained obstructive azoospermia, with and without CBA VD for CFTR gene 
mutations. 
Impaired spermatogenesis in men with CBA VD was recently described (Meng et al., 200 I). 
Apparently, defective CFTR function might influence spermatogenesis. Currently, we are 
investigating men with severe oligozoospermia for CFTR gene mutations by an extensive 
screening method of the CF-gene. 
Genetic risk factors associated with severe male infertility 
We were surprised to find 24% genetic risk factors in 150 infertile men screened for 
chromosomal abnormalities, Y chromosome deletions and CFTR gene mutations. Two men 
showed to have more than one risk factor. Our aim was to define subgroups of patients who 
need specific genetic tests by comparing the genetic screening results to the andrological 
evaluation. However, risk factors were found in men with and without male infertility 
associated factors. 
A nationwide cytogenetic study in the Netherlands of 1792 males with severe 
oligozoospermia and azoospermia showed 4.0% chromosomal abnormalities (Tuerlings eta!., 
1998). Numerical sex chromosomal aberrations and Robertsonian translocations 
predominated. Y chromosomal deletions were found in 5-15% of the infertile men, depending 
on the patients selection and the number of sequence tagged sites studied (Simoni eta!., 
1999). These microdeletions have been linked to variable defects in spermatogenesis, ranging 
from Sertoli cell-only syndrome to spermatogenic arrest. Transmission of these mutations to 
male offspring was recently reported (unpublished results). 
120 
We showed that combining different genetic tests for screening purposes results in a high 
number of men carrying one ore more genetic defects. The high ratio of anomalies found 
warrants genetic screening in all men applying for ICSI and not exclusively in case of 
unexplained male infertility. 
Ejaculatory duct obstructions 
The results of endoscopic treatment of ejaculatory duct obstructions were evaluated: simple 
incision of the prostatic cyst in men vvith ejaculatory duct obstruction resulted in only 
temporarily improvement of the semen in some men, but no spontaneous pregnancies 
occurred. Others achieved better results by combining deroofing of the midline prostatic cyst 
with transurethral opening of the ejaculatory ducts (Jarrow eta/., 1996). More recently, reflux 
of urine into the seminal vesicles was reported after this more extensive procedure, with risk 
of infection of the reproductive glands. We therefore advise caution with this procedure as to 
prevent permanent damage to the reproductive glands. Until now, sperm aspiration with ICSI 
seems a better solution for these couples. 
Microsurgery 
A review on the different microsurgical approaches of obstructions of the male reproductive 
tract and their prognostic factors is presented. Our experience with 214 procedures showed 
that with adequate training patency can be expected in 80-90% of the men. Spontaneous 
pregnancies occur in about half of the patent couples, and in 25% of the men vvith older 
female partners, slightly better than the results of sperm retrieval and ICSI in these couples. In 
men with a long obstructive interval concomitant obstructions in the epididymis may be found 
and a vasoepididymostomy is indicated. Sperm motility was significantly reduced in men vvith 
a long obstructive interval. resulting in less spontaneous pregnancies and more indications for 
artificial reproductive techniques. Efforts are needed to improve microsurgical techniques and 
urologists with an interest in andrology should be encouraged to learn the different 
microsurgical techniques. The operations are ideally performed in a center for reproductive 
medicine, thus allowing different options to be performed in selective cases. 
Sperm retrieval and ICSI 
We analyzed the first results in our center of surgical and percutaneous sperm retrieval with 
ICSI in men with CBA VD and failed microsurgery. Percutaneous sperm retrieval of 
epididymal sperm showed successful in 60-70% of the men and became the method of choice 
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for epididymal sperm harvesting. Microsurgical epididymal sperm aspiration (MESA) was 
abandoned in favor of percutaneous epididymal sperm aspiration (PESA). In 1996 it was 
decided to stop this treatment in the Netherlands, because of uncertainties about the possible 
transmission of genetic abnormalities from sperm derived from the epididymis and the testis. 
This treatment moratorium lasted for 5 years and was recently partially lifted in favor of 
epididymal sperm aspiration and ICSI in case of obstructive azoospermia. Research on 
epididymal spermatozoa showed no increase in DNA damage in epididymal spermatozoa 
compared to ejaculated spermatozoa from oligozoospermic men. 
The role of the andrologist 
Andrology is the subspecialty that deals with male reproductive health. The main topics of 
andrology are male infertility, male sexual dysfunction, male contraception and hormonal 
replacement therapy in ageing males. Andrology can contribute to reproductive medicine by 
studying the pathophysiology of disturbed spermatogenesis, epididymal insufficiency and 
obstructions of the male reproductive tract. This should lead to causative treatment for male 
infertility, risk assessment for transmission of genetic abnormalities and preventive 
measurements for optimal gonadal development. For the future, treatment of couples with 
infertility should be concentrated in joint clinics for reproductive medicine, combining experts 
in the field of reproductive health, clinical genetics and sexology for optimal patient care. 
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Obstructive male infertility 
Male infertility due to obstructions of the reproductive tract is present in 10-20% of the men 
with azoospermia. In this thesis diagnosis and treatment of obstructive male infertility are 
discussed. 
Obstructions of the male reproductive can be classified into congenital and acquired forms of 
ductal obstruction. Epididymal obstruction can be the consequence of blocks in the capital 
part of the organ, also known as Young's syndrome, infections of the epididymis and surgical 
damage to the organ. Vas deferens obstructions are usually the result of previous surgery, like 
vasectomy, hernia repair and orchidopexia. In 1-2% of the men with azoospermia congenital 
bilateral absence of the vas deferens is found (CBA VD), a genital form of cystic fibrosis. 
Ejaculatory duct obstruction can be caused by cystic lesions in the prostate, like Mullerian 
cysts, and prostatitis. 
Clinical aspects 
The clinical picture of men with bilateral obstruction of the reproductive tract shows 
azoospermia, normal testicular volume and normal gonadotrophins. Sometimes, severe 
oligozoospermia is found together with normal physical examination and normal follicle 
stimulating hormone (FSH). We routinely performed testicular biopsies in men with less than 
1 million spermatozoa!ml in their semen analysis and found normal spermatogenesis to be 
present in 50%. Subtotal obstruction of the male reproductive tract was found to be a frequent 
cause of severe oligozoospermia, especially in men with normal testicular volume and normal 
FSH. Next to artificial reproductive techniques (ART), like intracytoplasmic sperm injection 
(ICSI), surgical treatment with vasography and vaso-epididymostomy should be considered in 
these cases. Microsurgical repair can be performed in 80% of the men with normal 
spermatogenesis and azoospermia or severe oligospermia and is effective in 50-60% of cases. 
Natural conception and less invasive forms of ART are feasible in these couples with lower 
costs and less complications during pregnancy. Also, the potential risks of transmitting an 
inheritable disease is not increased as in ICSI, due to the absence of natural sperm selection. 
Therefore, surgical sperm retrieval and ICSI in case of obstructive male infertility should be 
reserved for patients that appear surgically irreparable. 
Congenital bilateral absence of the vas deferens 
A form of irreparable obstruction is congenital bilateral absence of the vas deferens. Since 
CBA VD and cystic fibrosis (CF) share the same genetic background we investigated men 
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with CBA VD for symptoms of CF and found that defective cellular chloride transport to be 
present in 11/21 patients. Furthermore, CF-related symptoms, like obstructive lung disease 
and pancreatic insufficiency was found in 6 men, thus showing that a majority of men with 
CBA VD actually have a subclinical form of cystic fibrosis. Cystic fibrosis gene mutations 
were found in 66% of CBA VD patients. Genetic testing and counselling is clearly indicated 
for these couples seeking pregnancy through epididymal or testicular sperm aspiration and 
ICSI. If the partner of the CBA VD patient also carries a CF-gene mutation the situation 
becomes complex, as no precise prediction can be made on the different phenotypes of CF 
(CBA VD, mild CF, severe CF) for most CF-gene mutations. 
Other genetic risk factors involved in infertile men with severe oligozoospermia and 
azoospermia are constitutive chromososme abnormalities and microdeletions of theY 
chromosome (Azoospermia factor region, AZF). In a cohort of 150 men screened for CF-gene 
mutations, cytogenetic abnormalities and AZF deletions of theY chromosome, a genetic risk 
factor was found to be present in 17% of men with severe oligozoospermia and 34% of men 
with azoospermia. Application of ICSI in the couples can result in offspring with an enhanced 
risk for unbalanced chromosome complement, male infertility due to the transmission of a Y 
chromosome microdeletion, and a form of cystic fibrosis (CF, CBA VD). Therefore, genetic 
testing and counselling is indicated for all couples seeking reproduction through ICSI. 
Ejaculatory duct obstruction 
Obstructions of the ejaculatory ducts are characterized by severe oligozoospermia or 
azoospermia and a low seminal volume. On transrectal ultrasound investigation cystic lesions 
of the prostatic gland and dilatation of the seminal vesicles can be found. In a follow-up study 
of 11 cases treatment of obstructions of the ejaculatory ducts in men with midline prostatic 
cysts showed unsuccessful. Although improvement of seminal volume was observed in some 
men, transurethral deroofmg of the midline prostatic cyst did not show any effect on sperm 
concentration and did not result in any durable effect or spontaneous pregnancy. The poor 
efficacy of this operation might be due concomitant epididymal obstructions or secondary 
stenosis/fibrosis of the ejaculatory ducts after marsupialization of the cyst. Also, the prostatic 
cyst might not be the cause of the obstruction. Resection of the wall of the cyst might improve 
the results of transurethral resection of the ejaculatory ducts in some men. 
Microsurgery 
127 
Vasectomy is a popular procedure in Western Europe: about 10-15% of the men rely on this 
form of definitive contraception. Due to the high divorce rate in most western countries the 
demand for vasectomy reversal is increasing. A vasovasostomy (VVS) is performed in 6 %of 
the vasectomised men. We have presented our results of the microsurgical VVS procedure in 
a review of the literature on microsurgical repair of the male reproductive tract. In a series of 
223 VVS procedures patency was accomplished in 84% and spontaneous pregnancy occurred 
in 50% of the couples, if the interval between vasectomy and reversal was less than 10 years 
and the age of the female partner was <37 years. The procedure was less successful in couples 
with a long interval and with older female partners: patency was still 66%, but spontaneous 
pregnancy decreased to 22%. These results are similar to the results of surgical sperm 
retrieval and ICSI, but the cost are much in favour of microsurgery. Also, simultaneous 
treatment of the partner and multiple pregnancies are avoided as in IVF/ICSL Microsurgical 
repair of obstructive male infertility is a challenge for the physician, but training and 
experience are required for good results. Fertility can often be restored, thus avoiding the need 
for ART. The procedures can be combined with sperm aspiration and cryopreservation, to be 
used for ICSI in cases of failed microsurgery. Urologists with an interest in Andrology should 
be encouraged to learn microsurgery as part of their surgical training. The operations are best 
performed in centres for reproductive medicine, allowing different options to be performed in 
selective cases. 
Sperm retrieval and ICSI 
Finally, we analysed the results of surgical sperm retrieval and ICSI in 39 cycles performed in 
24 couples. The sperm aspiration procedure was performed in men after failed microsurgery, 
in men with CBA VD and in men with a history of genital infections, which resulted in 
multiple obstructions of the reproductive tract. Initially, we performed microsurgical 
epididymal sperm aspiration (MESA) as a primary procedure for sperm harvesting and 
testicular sperm extraction (TESE) in case no spermatozoa could be aspirated from the 
epididymis. The MESA procedure was abandoned in favour of percutaneous epididymal 
sperm aspiration (PESA), because this procedure showed equal results in sperm harvesting 
with less discomfort for the patient. Fertilization occurred in 47% of the metaphase II oocytes; 
embryo transfer was performed in 92% of the procedures and resulted in ongoing pregnancies 
in I 0/39 (25%) procedures. One pregnancy was terminated early for a fetal cytogenetic 
abnormality. The other nine pregnancies resulted in the live birth of I 0 children, without any 
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congenital abnormalities. Non-obstructed cases of azoospermia were excluded from this 
treatment due to their potential genetic risks for the offspring. 
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Obstructies van de mannelijke tractus genitalis 
Ongewenste kinderloosheid wordt gevonden bij circa 15% van de paren. In de helft van de 
gevallen is er sprake van een mannelijke stoomis en meestal gaat het om een af\vijking van 
het sperma. Bij 10-20% van de mann en met vruchtbaarheidsstoomissen zijn er geen 
zaadcellen aanwezig in het sperma als gevolg van een verstopping van de zaadwegen. Dit 
proefschrift behandeld de diagnostiek en behandeling van obstructies van zaadwegen, de 
tractus genitalis. 
Obstructies van de tractus genitalis van de man h.'UIIDen worden onderverdeeld in aangeboren 
af\v:ijkingen en verkregen vormen van zaadwegverstopping. Verstoppingen van de bijbal 
(epididymis), waar de zaadcellen uitrijpen om uiteindelijk de eicellen te kunnen bevruchten, 
kunnen het gevolg zijn van een aangeboren aanlegstoornis van de afvoergangen in de kop van 
het orgaan, het zgn. Young's syndroom. Verkregen vormen van bijbalobstructie zijn vaak het 
gevolg van infecties of eerder uitgevoerde operaties in het scrotum. Obstructies van de 
zaadleiders worden meestal veroorzaakt door chirurgische behandelingen, zeals sterilisatie 
(vasectomie), liesbreukcorrectie en operaties voor niet-ingedaalde testikels. Van aile mannen 
met vruchtbaarheidsstoornissen wordt 1-2% geboren zonder zaadleiders (vas deferens), een 
genitale vorm van taaislijmziekte ( cystische fibrose, CF). Verstoppingen van het laatste deel 
van de zaadwegen, de ductus ejaculatorius worden veroorzaakt door cystes van Miille r in de 
prostaat, die de afvoergang van het sperma geheel of gedeeitelijk kan dichtdrukken, en door 
ontstekingen van de prostaatklier. 
Klinisch beeld 
Kerunerkend voor totale obstructie van de zaadwegen is het volledig ontbreken van 
zaadcellen in het sperma, terwijl het volume van de testikels normaal is en hormoononderzoek 
geen afwijking oplevert. Wij hebben onderzoek gedaan naar mannen met een zeer gering 
aantal zaadcellen in het sperma om te onderzoeken of er wellicht sprake is van een bijna totale 
obstructie.Bij a11e mann en met minder dan 1 miljoen zaadcellenfml in het sperma werd 
weefselonderzoek (biopsie) venicht van de testikels. Bij 50% van de mannen was er sprake 
van een normale spermaproductie in de testis. Obstructies van de zaadwegen zijn dus een 
vaak voorkomende oorzaak van ernstige sperma-afwijkingen, vooral bij mannen met normale 
testikels en normaal hormoononderzoek. Naast geassisteerde voortplantingstechnieken, zeals 
intracytoplasmatische sperma injectie (ICSI), bestaat bij deze mannen ook de mogelijkheid 
om operatief de obstructie te behandelen en zo de sperma1...-waliteit te verbeteren, zodat een 
spontane zwangerschap tot de mogelijkheden behoord en ook minder ingrijpende 
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voortplantingstechnieken, zoals inseminatie, k-unnen worden toegepast. Microchirurgische 
behandeling van obstructies is mogelijk bij ongeveer 80% van de mannen met een normale 
spermaproductie en leidt bij 50~60% van deze mannen tot een verbetering van de 
spermakwaliteit. Naast een reele kans op een spontane v.vangerschap en lagere totale kosten, 
is ook het risico voor overdracht van erfelijke aandoeningen kleiner dan bij de ICSI 
behandeling. ICSI dient daarom aileen te worden toegepast bij obstructies die niet 
toegankelijk zijn voor chirurgische behandeling ofna een mislul.'ie operatieve ingreep. 
Congenitale afwezigheid van het vas deferens 
Een vorm van aangeboren obstructie die niet chirurgisch gecorrigeerd kan worden is de 
congenitale bilaterale afwezigheid van het vas deferens (CBA VD), een genitale vorm van 
cystische fibrose. Omdat CBA VD en CF genetisch venvant zijn, is door ons onderzoek 
gedaan naar verschijnselen van taaislijmziekte bij mannen zonder zaadleiders. Het bleek dat 
11121 onderzochte mannen op subklinisch niveau verschijnselen hadden van CF en dat bij 6 
mannen ook afwijkingen er ook afwijkingen van de luchtwegen of de alvleesklier aanwezig 
waren. CBA VD is dus bij een belangrijk deel van deze mannen een milde vorm van cystische 
fibrose. Bij 66% van de onderzochte mannen werd een oftwee afwijkingen van het CF-gen 
gevonden, die overdraagbaar zijn aan het nageslacht. Het is daarom van groot belang om 
genetisch onderzoek van de patient en zijn partner te verrichten, voorafgaand aan 
zaadcelaspiratie en ICSI. Als ook de partner draagster blijkt te zijn van een CF-gen mutatie, 
zoals voorkomt bij 3-4% van de westerse bevolking, wordt de situatie complex: er bestaat dan 
een kans van 25-50% op een kind met een vorm van taaislijmziek'ie. Helaas is niet 
nauwkeurig te voorspellen welke vorm van CF ( emstig, mild, CBA VD) past bij welke 
mutaties. 
Andere genetische risicofactoren bij mannen met azoospermie en emstige oligozoospermie 
zijn cytogenetische afwijkingen en deleties van het Y ~chromosoom, de ''Azoospermia factor'' 
(AZF) regio. In een cohort van 150 mannen werd genetisch onderzoek verricht naar mutaties 
van het CF~gen, cytogenetische afwijkingen en deleties van het Y ~chromosoom: er werden 
34% afwijkingen gevonden bij mannen met azoospermie en 17% afwijkingen bij mannen met 
emstige oligozoospermie. In deze situatie bestaat een verhoogde kans op nageslacht met een 
vorm van taaislijmziekte, onvruchtbaarheid bij mannelijke nakomelingen die de AZF deletie 
overerven en multipele congenitale afwijkingen bij sommige cytogenetische afwijkingen. 
Daarom dient in geval van ICSI altijd genetisch onderzoek te worden verricht, voorafgaande 
aan de behandeling. 
133 
Obstructies van de ductus ejaculatorius 
Obstructies van de ductus ejaculatorius worden gekenmerkt door azoospermie of emstige 
oligozoospermie en een klein spermavolume. Transrectaal onderzoek van de prostaat en de 
zaadblaasjes laat bij deze mannen regelmatig een cyste zien in de prostaat en stuwing van de 
zaadblaasjes. Een vervolgonderzoek van 11 mannen die werden behandeld voor een midline 
cyste in de prostaat liet weinig of geen verbetering zien van de spermakwaliteit: alleen bij 
enkele mann en werd een tijdelijke verbetering gezien van het spermavolume. Enige blijvende 
verbetering of zwangerschap werd niet waargenomen. Het teleurstellende resultaat van deze 
behandeling kan worden verklaard doordat bij een aantal mannen er mogelijk ook een 
obstructie van de epididymis bestaat of omdat de behandeling heeft geleid tot een nieuwe 
vemauwing door littekenvorming. Ook kan het zo zijn dat de prostaatcyste niet de oorzaak 
van de obstructie was. Mogelijk is het resultaat te verbeteren door niet aileen de cyste te 
openen, maar ook de wand te openen van de cyste waar de ductus ejaculatorius loopt. 
Microchirurgie 
Vasectomie (sterilisatie van de man) is een populaire vorm van defmitieve anticonceptie in de 
meeste West-Europese Ianden: 10-15% van de mannen laat zich steriliseren. Als gevolg van 
de toename van het aantal echtscheidingen neemt ook de vraag naar hersteloperaties na 
vasectomie, de zgn. vasovasostomie, toe: bij 6% van de gesteriliseerde mannen wordt deze 
hersteloperatie uitgevoerd. In een literatuurstudie naar de resultaten van microchirurgische 
behandeling van mannelijke onvruchtbaarheid hebben wij de resultaten gepresenteerd van 223 
hersteloperaties: doorgankelijkheid werd bereikt bij 84% van de mannen en een spontane 
zwangerschap trad op bij 50% van de partners, indien de sterilisatie korter dan I 0 jaar gel eden 
was uitgevoerd en de partner jonger was dan 37 jaar. Bij een Ianger interval en een oudere 
partner daalde de resultaten naar 66% doorgankelijkheid en 22% spontane zwangerschappen, 
vergelijkbaar met de zwangerschapsresultaten bij in vitro fertilisatie/ICSI. De voordelen van 
microchirurgie zijn echter: lagere kosten per zwangerschap, geen belastende hormonale 
behandeling van de partner en waa.rschijnlijk minder genetische risico 's voor het nageslacht. 
Microchirurgische behandeling van mannelijke infertiliteit is een uitdaging voor de uroloog 
en goede resultaten worden pas verlcregen na voldoende ervaring en zorgvuldige techniek. 
Urologen met belangstelling voor Andrologie dienen gestimuleerd te worden om 
microchirurgie te leren als deel van de opleiding. Deze operaties dienen bij voorkeur te 
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worden verricht in een centrum voor voortplantingsgeneesk-unde, zodat verschillende opties 
aanwezig zijn voor specifi.eke probleemgevallen. 
Sperma aspiratie en ICSI 
Tot slot, hebben wij de resultaten geanalyseerd van 39 gecombineerde zaadcelaspiratie en 
ICSI behandeling bij 24 paren. Deze behandeling werd toegepast bij mannen met een 
mislukte rnicrochirurgische behandeling, bij congenitale afwezigheid van de zaadleiders en bij 
mannen die onvruchtbaar zijn geworden als gevolg van een genitale infectie met meerdere 
obstructies van de zaadwegen. In eerste instantie werd gekozen voor de microchirurgisch 
epididymale sperma aspiratie (MESA) om zaadcellen te oogsten ofvoor de testiculaire 
sperma extractie (TESE) indien er geen zaadcellen werden gevonden in de bijbal. Echter, de 
.MESA werd al na 4 behandelingen vervangen door de even effectieve percutane epididymale 
sperma aspiratie (PESA), die als belangrijk voordeel heeft de minimale belasting voor de 
patient. Bevruchting trad op bij 47% van de metafase II eicellen en bij 92% van de paren werd 
1 ofmeerdere embryo's terug geplaatst. Een doorgaande zwangerschap trad op bij 10/39 
paren (25%) en resulteerde in 9 bevallingen van 10 gezonde kinderen. Een zwangerschap 
werd voortijdig beeindigd vanwege een cytogenetische a:furijking van de foetus, ontdekt door 
rniddel van een vruchtwateronderzoek. Deze behandeling werd aileen toegepast bij mannen 
met een aangetoonde obstructie van de zaadwegen. 
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